Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0009083 branched-chain amino acid catabolic process	IBA GO_REF:0000033	ACCEPT	Summary: Phylogenetically-inferred involvement of the E1-alpha subunit in branched-chain amino acid catabolism. This is the core biological process for BCKDHA and is well supported by biochemistry across orthologs; the IBA is at an appropriate level of specificity. Reason: BCKDHA is the E1-alpha subunit of the BCKDH complex, which performs the committed rate-limiting step of BCAA (leucine/isoleucine/valine) catabolism. Directly supported by biochemistry of the purified human complex and by MSUD disease biology. Supporting Evidence: PMID:3593587 The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km values in the range of 14-17 microM for those alpha-keto acids.
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex	IBA GO_REF:0000033	ACCEPT	Summary: Phylogenetically-inferred membership of E1-alpha in the branched-chain alpha-ketoacid dehydrogenase complex. Correct and well supported; E1-alpha (with E1-beta) forms the E1 heterotetramer that is part of the complete BCKDH complex assembled on the E2/DBT core. Reason: The alpha2-beta2 E1 heterotetramer is an integral part of the BCKDH complex, demonstrated structurally and biochemically for the human enzyme. Supporting Evidence: PMID:10745006 the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain alpha-ketoacid dehydrogenase multienzyme complex
GO:0003863 branched-chain 2-oxo acid dehydrogenase activity	IEA GO_REF:0000120	ACCEPT	Summary: Electronic annotation of the E1 branched-chain 2-oxo acid dehydrogenase activity (EC 1.2.4.4; RHEA:13457, RHEA:84639, RHEA:84643), corresponding to the specific molecular function of the BCKDH E1 component and matching the UniProt catalytic activity reactions. This is the correct core molecular function. Reason: The IEA (EC/RHEA-mapped) term precisely matches the reaction catalyzed by the E1 component to which E1-alpha contributes; it is corroborated by experimental IDA annotations to the same term. Supporting Evidence: PMID:3593587 The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km values in the range of 14-17 microM for those alpha-keto acids.
GO:0005759 mitochondrial matrix	IEA GO_REF:0000044	ACCEPT	Summary: Electronic mapping from the UniProt subcellular location keyword (mitochondrion matrix). Correct; the mature protein is imported into the mitochondrial matrix after cleavage of its N-terminal transit peptide, where the BCKDH complex functions. Reason: Mitochondrial matrix localization is directly established by the crystal structure/UniProt subcellular location and consistent with the presence of a cleavable mitochondrial transit peptide (residues 1-45). Supporting Evidence: PMID:10745006 the branched-chain alpha-ketoacid dehydrogenase multienzyme complex
GO:0016624 oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor	IEA GO_REF:0000002	MODIFY	Summary: InterPro2GO (IPR001017, DH_E1) electronic mapping to the parent oxidoreductase term. GO:0016624 is the direct is_a parent of the specific BCKDH E1 activity GO:0003863, so it is not wrong, but it is unnecessarily general for E1-alpha given that the specific decarboxylase function is already annotated. Reason: The annotation is a legitimate but overly broad electronic parent term. The specific molecular function GO:0003863 (branched-chain 2-oxo acid dehydrogenase activity), which is_a GO:0016624, is already supported by experimental (IDA) and EC/RHEA (IEA) evidence and should be used instead. Proposed replacements: branched-chain 2-oxo acid dehydrogenase activity
GO:0005515 protein binding	IPI PMID:12902323 Roles of His291-alpha and His146-beta' in the reductive acyl...	MARK AS OVER ANNOTATED	Summary: Bare protein binding IPI with WITH/FROM = UniProtKB:P21953 (BCKDHB), i.e. the physiological E1-alpha/E1-beta interaction underlying the alpha2-beta2 heterotetramer. The interaction itself is real and central, but the GO term protein binding is uninformative and does not convey the functional relationship. Reason: Per curation guidelines, bare protein binding is uninformative. The biologically meaningful content (E1-alpha/E1-beta heterotetramer) is captured by the complex-membership annotation GO:0160157 and by core_functions; this IPI adds no functional specificity.
GO:0005515 protein binding	IPI PMID:15166214 Cross-talk between thiamin diphosphate binding and phosphory...	MARK AS OVER ANNOTATED	Summary: Bare protein binding IPI with WITH/FROM = UniProtKB:P21953 (BCKDHB) from a mechanistic study of the human E1b decarboxylase (thiamine diphosphate binding / phosphorylation-loop conformation), i.e. again the E1-alpha/E1-beta interaction. Reason: The underlying E1-alpha/E1-beta interaction is genuine but the protein binding term is uninformative; the heterotetramer is already represented by GO:0160157 complex membership and core_functions.
GO:0005515 protein binding	IPI PMID:15576032 Molecular mechanism for regulation of the human mitochondria...	MARK AS OVER ANNOTATED	Summary: Bare protein binding IPI with WITH/FROM = UniProtKB:P21953 (BCKDHB) from a study of phosphorylation-based regulation of the human BCKDH complex; the recorded interaction is the E1-alpha/E1-beta pairing within E1. Reason: Uninformative MF term. The functionally meaningful E1-alpha/E1-beta association is captured by the complex membership annotation (GO:0160157) and core_functions.
GO:0005515 protein binding	IPI PMID:28514442 Architecture of the human interactome defines protein commun...	MARK AS OVER ANNOTATED	Summary: Bare protein binding IPI (BioPlex 2.0 large-scale AP-MS interactome) with WITH/FROM = UniProtKB:P21953 (BCKDHB). High-throughput guilt-by-association evidence recapitulating the E1-alpha/E1-beta interaction. Reason: Uninformative protein binding term derived from a high-throughput screen; the E1-alpha/E1-beta relationship is already represented more informatively by GO:0160157.
GO:0005515 protein binding	IPI PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling...	MARK AS OVER ANNOTATED	Summary: Bare protein binding IPI (BioPlex 3.0 large-scale AP-MS interactome) with WITH/FROM = UniProtKB:P21953 (BCKDHB). High-throughput evidence again capturing the E1-alpha/E1-beta interaction. Reason: Uninformative MF term from a high-throughput interactome; the E1-alpha/E1-beta association is already represented by GO:0160157 and core_functions.
GO:0005759 mitochondrial matrix	NAS PMID:3593587 Purification and characterization of human liver branched-ch...	ACCEPT	Summary: ComplexPortal (CPX-2216) NAS annotation to mitochondrial matrix, consistent with the localization of the purified human liver BCKDH complex and with the crystallographic/UniProt subcellular location. Correct localization. Reason: Mitochondrial matrix localization is well established for the BCKDH complex that contains E1-alpha; this NAS is corroborated by IEA (SubCell), ISS, and TAS annotations to the same term.
GO:0009083 branched-chain amino acid catabolic process	IDA PMID:3593587 Purification and characterization of human liver branched-ch...	ACCEPT	Summary: Direct experimental evidence (ComplexPortal, IDA) that the purified human liver BCKDH complex oxidizes the three branched-chain 2-oxo acids (KIV, KIC, KMV), placing E1-alpha in the BCAA catabolic process. This is the core biological process. Reason: The purified complex biochemically catabolizes all three branched-chain 2-oxo acids, directly demonstrating involvement in BCAA catabolism. Supporting Evidence: PMID:3593587 The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km values in the range of 14-17 microM for those alpha-keto acids.
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex	IPI PMID:3593587 Purification and characterization of human liver branched-ch...	ACCEPT	Summary: ComplexPortal (CPX-2216) evidence that E1-alpha is a subunit of the branched-chain alpha-ketoacid dehydrogenase complex, based on purification/characterization of the human liver complex showing the constituent subunits. Correct. Reason: The purified human liver complex resolves into its component subunits (including the ~46-51 kDa E1-alpha/E1-beta bands), establishing E1-alpha as part of the BCKDH complex. Supporting Evidence: PMID:3593587 the purified enzyme complex gave three major bands having molecular weights of 51,000, 46,000, and 36,000
GO:0005759 mitochondrial matrix	ISS GO_REF:0000024	ACCEPT	Summary: ISS transfer from rat ortholog (UniProtKB:P11178) asserting that E1-alpha is active in the mitochondrial matrix. Consistent with all other localization evidence; the is_active_in qualifier appropriately reflects where the enzyme carries out its function. Reason: Mitochondrial matrix is the established site of BCKDH function; the ISS is consistent with the direct human localization data.
GO:0120552 branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA	IMP PMID:10745006 Crystal structure of human branched-chain alpha-ketoacid deh...	ACCEPT	Summary: IMP from the crystal structure/mutational analysis of human E1b, in which MSUD-causing E1-alpha variants disrupt cofactor/K+ sites and subunit interfaces and abolish function, demonstrating the role of E1-alpha in the branched-chain 2-oxo acid decarboxylation-to-acyl-CoA process. This BP term precisely captures the pathway role of the complex. Reason: MSUD mutations in E1-alpha interfere with the cofactor and K+ sites and subunit interfaces, impairing the decarboxylation process, providing mutational (IMP) evidence for E1-alpha involvement. Supporting Evidence: PMID:10745006 The known MSUD mutations affect the functioning of E1b by interfering with the cofactor and K(+) sites, the packing of hydrophobic cores, and the precise arrangement of residues at or near several subunit interfaces.
GO:0120552 branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA	IDA PMID:3593587 Purification and characterization of human liver branched-ch...	ACCEPT	Summary: IDA that the purified human BCKDH complex (containing E1-alpha) carries out oxidative decarboxylation of the branched-chain 2-oxo acids to yield NADH (and, via the coupled reactions, branched-chain acyl-CoA), placing E1-alpha in this pathway. Reason: The purified complex oxidizes KIV/KIC/KMV in a CoA- and NAD-dependent reaction, the biochemical hallmark of the branched-chain 2-oxo acid decarboxylation-to-acyl-CoA pathway. Supporting Evidence: PMID:3593587 NAD and CoASH were absolutely required for the reaction.
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-9865121	ACCEPT	Summary: Reactome TAS localization of the BCKDH reaction to the mitochondrial matrix. Correct and consistent with all other localization evidence. Reason: Reactome curates the BCKDH-catalyzed reaction as occurring in the mitochondrial matrix, consistent with the experimental localization of the complex.
GO:0005739 mitochondrion	HTP PMID:34800366 Quantitative high-confidence human mitochondrial proteome an...	ACCEPT	Summary: High-throughput (HTP) mitochondrial proteome assignment. Correct but less specific than the matrix localization; retained as a broader, consistent localization. Reason: High-confidence mitochondrial proteome data place E1-alpha in the mitochondrion; this is a correct broader parent of the mitochondrial matrix localization. Supporting Evidence: PMID:34800366 Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex	IDA PMID:7883996 Molecular and biochemical basis of intermediate maple syrup ...	ACCEPT	Summary: IDA from a study of intermediate MSUD in which homozygous E1-alpha missense mutations (G245R, F364C) disrupt E1 heterotetrameric (alpha2-beta2) assembly and BCKAD complex function, directly demonstrating E1-alpha as a subunit of the complex. Reason: Mutant E1-alpha subunits fail to assemble the alpha2-beta2 E1 tetramer and reconstitute BCKAD activity, establishing E1-alpha membership in the BCKDH complex. Supporting Evidence: PMID:7883996 G245R and F364C mutations in the E1 alpha subunit disrupt both the E1 heterotetrameric assembly and function of the BCKAD complex
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex	IDA PMID:9582350 Impaired assembly of E1 decarboxylase of the branched-chain ...	ACCEPT	Summary: IDA showing the human E1 decarboxylase comprises two E1-alpha and two E1-beta subunits forming an alpha2-beta2 tetramer that is part of the BCKAD complex, with type IA MSUD E1-alpha mutations impairing assembly. Directly establishes complex membership. Reason: Reconstitution/assembly experiments define the alpha2-beta2 E1 component containing E1-alpha as part of the branched-chain ketoacid dehydrogenase complex. Supporting Evidence: PMID:9582350 The E1 decarboxylase component of the human branched-chain ketoacid dehydrogenase complex comprises two E1alpha (45.5 kDa) and two E1beta (37.5 kDa) subunits forming an alpha2 beta2 tetramer.
GO:0160157 branched-chain alpha-ketoacid dehydrogenase complex	IDA PMID:10745006 Crystal structure of human branched-chain alpha-ketoacid deh...	ACCEPT	Summary: IDA from the crystal structure of the human alpha2-beta2 E1b heterotetramer, the E1 component of the BCKDH multienzyme complex, directly demonstrating E1-alpha as a structural subunit of the complex. Reason: The crystal structure resolves the alpha2-beta2 E1b heterotetramer as the E1 component of the branched-chain alpha-ketoacid dehydrogenase complex. Supporting Evidence: PMID:10745006 the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain alpha-ketoacid dehydrogenase multienzyme complex
GO:0003863 branched-chain 2-oxo acid dehydrogenase activity	IDA PMID:10745006 Crystal structure of human branched-chain alpha-ketoacid deh...	ACCEPT	Summary: IDA (contributes_to) linking E1-alpha to the branched-chain 2-oxo acid dehydrogenase molecular function of the E1 component. The contributes_to qualifier is appropriate because the activity is a property of the E1-alpha/E1-beta heterotetramer to which E1-alpha contributes catalytic residues (TPP/Mg2+ binding site). This is the core molecular function. Reason: The crystal structure with TPP, K+ and Mg2+ and characterization of MSUD variants (loss of 3-methyl-2-oxobutanoate dehydrogenase activity) establishes the contribution of E1-alpha to the branched-chain 2-oxo acid dehydrogenase activity. Supporting Evidence: PMID:10745006 The known MSUD mutations affect the functioning of E1b by interfering with the cofactor and K(+) sites
GO:0003863 branched-chain 2-oxo acid dehydrogenase activity	IDA PMID:9582350 Impaired assembly of E1 decarboxylase of the branched-chain ...	ACCEPT	Summary: IDA (contributes_to) showing that E1-alpha is required for E1 and BCKAD catalytic activities; type IA MSUD E1-alpha mutations cause loss of these activities. Core molecular function to which E1-alpha contributes within the heterotetramer. Reason: In type IA MSUD the affected E1-alpha subunit results in loss of E1 and BCKAD catalytic activities, demonstrating the contribution of E1-alpha to the branched-chain 2-oxo acid dehydrogenase activity. Supporting Evidence: PMID:9582350 the E1alpha subunit is affected, resulting in the loss of E1 and branched-chain ketoacid dehydrogenase catalytic activities
GO:0009083 branched-chain amino acid catabolic process	IMP PMID:9582350 Impaired assembly of E1 decarboxylase of the branched-chain ...	ACCEPT	Summary: IMP evidence that E1-alpha function is required for branched-chain ketoacid dehydrogenase activity, the committed step of BCAA catabolism; type IA MSUD E1-alpha mutations abolish this activity. Core biological process. Reason: Loss of E1-alpha function in type IA MSUD abolishes BCKAD catalytic activity, the committed step of BCAA catabolism, providing mutational evidence for involvement in the process. Supporting Evidence: PMID:9582350 the E1alpha subunit is affected, resulting in the loss of E1 and branched-chain ketoacid dehydrogenase catalytic activities
GO:0005739 mitochondrion	HDA PMID:20833797 Phosphoproteome analysis of functional mitochondria isolated...	ACCEPT	Summary: High-throughput direct assay (HDA) mitochondrial phosphoproteome localization. Correct but broader than the matrix localization; consistent supporting evidence. Reason: Phosphoproteomic analysis of functional mitochondria localizes E1-alpha to the mitochondrion, a correct broader parent of the mitochondrial matrix localization. Supporting Evidence: PMID:20833797 Phosphoproteome analysis of functional mitochondria isolated from resting human muscle
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-5693148	ACCEPT	Summary: Reactome TAS localization to the mitochondrial matrix. Correct and consistent with all other localization evidence. Reason: Reactome curates the BCKDH reaction/subunits to the mitochondrial matrix, consistent with experimental localization.
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-5693153	ACCEPT	Summary: Reactome TAS localization to the mitochondrial matrix. Correct; duplicate of the well-supported matrix localization. Reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-9859148	ACCEPT	Summary: Reactome TAS localization to the mitochondrial matrix (BCKDHA:BCKDHB tetramer decarboxylates KIC, KMVA, KIV reaction). Correct localization of the E1-catalyzed step. Reason: Reactome localizes the E1 (BCKDHA:BCKDHB) decarboxylation reaction to the mitochondrial matrix, consistent with experimental data.
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-9859163	ACCEPT	Summary: Reactome TAS localization to the mitochondrial matrix. Correct; consistent with all other localization evidence. Reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-9859172	ACCEPT	Summary: Reactome TAS localization to the mitochondrial matrix (DLD dimer dehydrogenates dihydrolipoyl step of the BCKDH complex). Correct localization; annotated to E1-alpha as part of the same complex. Reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-9865115	ACCEPT	Summary: Reactome TAS localization to the mitochondrial matrix. Correct; consistent duplicate of the matrix localization. Reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-9907572	ACCEPT	Summary: Reactome TAS localization to the mitochondrial matrix. Correct; consistent duplicate of the matrix localization. Reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-9912480	ACCEPT	Summary: Reactome TAS localization to the mitochondrial matrix. Correct; consistent duplicate of the matrix localization. Reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
GO:0005759 mitochondrial matrix	TAS Reactome:R-HSA-9912527	ACCEPT	Summary: Reactome TAS localization to the mitochondrial matrix (H139Hfs13* PPM1K does not dephosphorylate BCKDH). Correct localization of the regulated BCKDH reaction. Reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
GO:0003863 branched-chain 2-oxo acid dehydrogenase activity	IDA PMID:7883996 Molecular and biochemical basis of intermediate maple syrup ...	ACCEPT	Summary: IDA (enables) that E1-alpha is required for branched-chain 2-oxo acid dehydrogenase activity; intermediate MSUD E1-alpha mutations (G245R, F364C) abolish reconstitution of BCKAD activity. This is the core molecular function of the gene product. Reason: Both intermediate-MSUD E1-alpha mutant subunits fail to reconstitute BCKAD activity, demonstrating the requirement of E1-alpha for the branched-chain 2-oxo acid dehydrogenase activity. Supporting Evidence: PMID:7883996 both G245R and F364C mutant E1 alpha subunits were unable to significantly reconstitute BCKAD activity
GO:0009083 branched-chain amino acid catabolic process	IDA PMID:7883996 Molecular and biochemical basis of intermediate maple syrup ...	ACCEPT	Summary: IDA that E1-alpha function is required for BCKAD complex activity, the committed step of BCAA catabolism, whose loss (via E1-alpha mutation) causes intermediate MSUD. Core biological process. Reason: E1-alpha mutations that abolish BCKAD activity cause MSUD (a BCAA catabolic defect), demonstrating involvement of E1-alpha in branched-chain amino acid catabolism. Supporting Evidence: PMID:7883996 G245R and F364C mutations in the E1 alpha subunit disrupt both the E1 heterotetrameric assembly and function of the BCKAD complex
GO:0005739 mitochondrion	TAS PMID:11839747 Solution structure and dynamics of the lipoic acid-bearing d...	ACCEPT	Summary: TAS (HGNC-UCL) mitochondrial localization derived from a study of the human BCKD complex (E2 lipoyl-bearing domain). Correct but broader than the matrix localization; the paper concerns the E2/DBT lipoyl domain rather than E1-alpha specifically, and is used here as curator-transferred general localization for the complex. Reason: Mitochondrial localization of the BCKD complex is correct; retained as a broader parent of the mitochondrial matrix localization. Supporting Evidence: PMID:11839747 the human branched-chain alpha-keto acid dehydrogenase complex
GO:0016831 carboxy-lyase activity	TAS PMID:11839747 Solution structure and dynamics of the lipoic acid-bearing d...	MARK AS OVER ANNOTATED	Summary: TAS (HGNC-UCL) carboxy-lyase activity, a generic parent capturing the decarboxylation (CO2-releasing) chemistry of the E1 reaction. The reference is actually an NMR study of the E2 lipoyl domain, so this is a curator-assigned broad term rather than a direct assay of E1-alpha carboxy-lyase activity. The specific molecular function is GO:0003863. Reason: Carboxy-lyase activity is a correct but overly general description of the E1 decarboxylation step; the precise molecular function branched-chain 2-oxo acid dehydrogenase activity (GO:0003863) is already annotated with experimental evidence and better represents the role of E1-alpha.
GO:0030976 thiamine pyrophosphate binding	IDA PMID:10745006 Crystal structure of human branched-chain alpha-ketoacid deh...	NEW	Summary: Not present in the seeded GOA but strongly supported. The crystal structure of human E1b resolves thiamine diphosphate bound at the E1-alpha/E1-beta interface, and UniProt annotates multiple TPP-binding residues on E1-alpha (positions 158, 159, 207, 239, 240, 265, 336 in mature numbering). Added as a NEW core molecular function for the essential cofactor. Reason: E1-alpha provides the diphosphate-binding residues of the shared thiamine diphosphate cofactor, which is essential for the decarboxylation reaction; this MF is documented crystallographically and by UniProt binding features but is missing from the current GOA. Supporting Evidence: PMID:10745006 One of these ions assists a loop that is close to the cofactor to adopt the proper conformation. file:human/BCKDHA/BCKDHA-deep-research-falcon.md The E1 component requires thiamine pyrophosphate (ThDP/TPP) as an essential cofactor
GO:0000287 magnesium ion binding	IDA PMID:10745006 Crystal structure of human branched-chain alpha-ketoacid deh...	NEW	Summary: Not present in the seeded GOA but supported by the crystal structure and UniProt binding features. Mg2+ is a required cofactor coordinated by E1-alpha residues (positions 238, 267, 269 in mature numbering) together with the thiamine diphosphate diphosphate moiety. Added as a NEW core molecular function. Reason: E1-alpha coordinates the catalytically required Mg2+ that anchors the diphosphate of thiamine diphosphate; documented crystallographically and by UniProt binding features but missing from the current GOA. Supporting Evidence: file:human/BCKDHA/BCKDHA-uniprot.txt Name=Mg(2+)

Core Functions

Thiamine-diphosphate-dependent branched-chain 2-oxo acid dehydrogenase (decarboxylase) activity of the E1 component; E1-alpha oxidatively decarboxylates the branched-chain 2-oxo acids derived from leucine, isoleucine and valine and reductively acylates the lipoyl-lysine of the E2 component (EC 1.2.4.4).

Molecular Function:

branched-chain 2-oxo acid dehydrogenase activity

Directly Involved In:

branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA

Cellular Locations:

mitochondrial matrix

In Complex:

branched-chain alpha-ketoacid dehydrogenase complex

Supporting Evidence:

PMID:10745006
the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain alpha-ketoacid dehydrogenase multienzyme complex
PMID:9582350
the E1alpha subunit is affected, resulting in the loss of E1 and branched-chain ketoacid dehydrogenase catalytic activities

As part of the branched-chain alpha-ketoacid dehydrogenase complex, contributes to the committed, rate-limiting step of branched-chain amino acid (leucine, isoleucine, valine) catabolism in the mitochondrial matrix.

Molecular Function:

branched-chain 2-oxo acid dehydrogenase activity

Directly Involved In:

branched-chain amino acid catabolic process

Cellular Locations:

mitochondrial matrix

In Complex:

branched-chain alpha-ketoacid dehydrogenase complex

Supporting Evidence:

PMID:3593587
The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km values in the range of 14-17 microM for those alpha-keto acids.

Binds the essential cofactor thiamine diphosphate (TPP/ThDP); the diphosphate-binding residues and associated divalent metal site reside on the E1-alpha subunit at the E1-alpha/E1-beta interface.

Molecular Function:

thiamine pyrophosphate binding

Cellular Locations:

mitochondrial matrix

In Complex:

branched-chain alpha-ketoacid dehydrogenase complex

Supporting Evidence:

PMID:10745006
One of these ions assists a loop that is close to the cofactor to adopt the proper conformation.

Binds Mg2+, required together with thiamine diphosphate for catalysis; the Mg2+-coordinating residues (positions 238, 267, 269 in mature numbering) are on the E1-alpha subunit.

Molecular Function:

magnesium ion binding

Cellular Locations:

mitochondrial matrix

In Complex:

branched-chain alpha-ketoacid dehydrogenase complex

References

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms

GO_REF:0000024

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000044

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

PMID:10745006

Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease.

The 2.7 A crystal structure of the human alpha2-beta2 heterotetrameric E1b component reveals the TPP, K+ and Mg2+ sites and explains how MSUD mutations disrupt function.

"the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain alpha-ketoacid dehydrogenase multienzyme complex"

PMID:11839747

Solution structure and dynamics of the lipoic acid-bearing domain of human mitochondrial branched-chain alpha-keto acid dehydrogenase complex.

NMR structure of the E2 (transacylase) lipoyl-bearing domain of the human BCKD complex; concerns the E2 lipoyl domain rather than E1-alpha directly.

"The lipoyl-bearing domain (LBD) of the transacylase (E2) subunit of the branched-chain alpha-keto acid dehydrogenase complex plays a central role in substrate channeling in this mitochondrial multienzyme complex."

PMID:12902323

Roles of His291-alpha and His146-beta' in the reductive acylation reaction catalyzed by human branched-chain alpha-ketoacid dehydrogenase: refined phosphorylation loop structure in the active site.

Mechanistic study of the human E1b reductive acylation reaction and active-site/phosphorylation-loop structure. Source of an E1-alpha/E1-beta protein-binding IPI.

"reductive acylation reaction catalyzed by human branched-chain alpha-ketoacid dehydrogenase"

PMID:15166214

Cross-talk between thiamin diphosphate binding and phosphorylation loop conformation in human branched-chain alpha-keto acid decarboxylase/dehydrogenase.

Links thiamine diphosphate binding to phosphorylation-loop conformation in human E1b. Source of an E1-alpha/E1-beta protein-binding IPI.

"Cross-talk between thiamin diphosphate binding and phosphorylation loop conformation in human branched-chain alpha-keto acid decarboxylase/dehydrogenase."

PMID:15576032

Molecular mechanism for regulation of the human mitochondrial branched-chain alpha-ketoacid dehydrogenase complex by phosphorylation.

Describes phosphorylation-based regulation of the human BCKDH complex. Source of an E1-alpha/E1-beta protein-binding IPI.

"Molecular mechanism for regulation of the human mitochondrial branched-chain alpha-ketoacid dehydrogenase complex by phosphorylation."

PMID:20833797

Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes.

High-throughput direct-assay mitochondrial phosphoproteome placing E1-alpha in the mitochondrion.

"Phosphoproteome analysis of functional mitochondria isolated from resting human muscle"

PMID:28514442

Architecture of the human interactome defines protein communities and disease networks.

BioPlex 2.0 AP-MS interactome; high-throughput source of the E1-alpha/E1-beta protein-binding IPI.

"Architecture of the human interactome defines protein communities and disease networks."

PMID:33961781

Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.

BioPlex 3.0 AP-MS interactome; high-throughput source of the E1-alpha/E1-beta protein-binding IPI.

"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome."

PMID:34800366

Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.

High-throughput high-confidence mitochondrial proteome placing E1-alpha in the mitochondrion.

"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context."

PMID:3593587

Purification and characterization of human liver branched-chain alpha-keto acid dehydrogenase complex.

The purified human liver BCKDH complex resolves into E1-alpha/E1-beta/E2 subunits and oxidizes KIV, KIC and KMV in a NAD- and CoA-dependent reaction.

"The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding apparent Km values in the range of 14-17 microM for those alpha-keto acids."

PMID:7883996

Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.

Homozygous E1-alpha missense mutations (G245R, F364C) disrupt alpha2-beta2 E1 assembly and abolish BCKAD activity, causing intermediate MSUD.

"G245R and F364C mutations in the E1 alpha subunit disrupt both the E1 heterotetrameric assembly and function of the BCKAD complex"

PMID:9582350

Impaired assembly of E1 decarboxylase of the branched-chain alpha-ketoacid dehydrogenase complex in type IA maple syrup urine disease.

The human E1 decarboxylase is an alpha2-beta2 tetramer of two E1-alpha and two E1-beta subunits; type IA MSUD E1-alpha mutations impair assembly and abolish E1/BCKAD catalytic activity.

"The E1 decarboxylase component of the human branched-chain ketoacid dehydrogenase complex comprises two E1alpha (45.5 kDa) and two E1beta (37.5 kDa) subunits forming an alpha2 beta2 tetramer."

Reactome:R-HSA-5693148

BCKDK phosphorylates BCKDH

Reactome:R-HSA-5693153

PPM1K dephosphorylates p-BCKDH

Reactome:R-HSA-9859148

BCKDHA:BCKDHB tetramer decarboxylates KIC, KMVA, KIV

Reactome:R-HSA-9859163

DBT transfers BCAA to CoA

Reactome:R-HSA-9859172

DLD dimer dehydrogenates dihydrolipoyl

Reactome:R-HSA-9865115

DBT loss-of-function mutants don't synthesize BCAA-CoA

Reactome:R-HSA-9865121

BCKDHA or BCKDHB loss-of-function mutants don't synthesize BCAA-CoA

Reactome:R-HSA-9907572

Loss-of-function DLD mutants don't dehydrogenate dihydrolipoyl DBT

Reactome:R-HSA-9912480

BCKDK loss-of-function mutations do not phosphorylate BCKDH

Reactome:R-HSA-9912527

H139Hfs13* PPM1K does not dephosphorylate BCKDH

Suggested Experiments

Experiment: Cryo-EM of the intact human BCKDH complex (E1/E2/E3 on the DBT core) in phosphorylated versus dephosphorylated states to resolve how E1-alpha phosphorylation-loop conformation gates the reductive acylation step.

Experiment: Reconstitution assays comparing kcat/Km of wild-type versus MSUD1A E1-alpha variants for KIC, KMV and KIV to test whether specific mutations differentially affect the three physiological substrates.

Deep Research

Falcon

(BCKDHA-deep-research-falcon.md)

Comprehensive Research Report: BCKDHA (Branched-Chain Keto Acid Dehydrogenase E1 Subunit Alpha) Falcon Edison Scientific Literature 47 citations 1 artifacts 2026-07-05T19:56:43.817105

Edison artifact artifact-00 (text/markdown)

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: BCKDHA (Branched-Chain Keto Acid Dehydrogenase E1 Subunit Alpha)

Gene and Protein Identity

BCKDHA (UniProt: P12694; HGNC:986) encodes the 2-oxoisovalerate dehydrogenase subunit alpha, a mitochondrial enzyme also known as branched-chain alpha-keto acid dehydrogenase E1 component alpha chain (BCKDH E1α). The protein is classified under EC 1.2.4.4 and belongs to the BCKDHA protein family. Key domains include the alpha-ketoacid dehydrogenase E1 component domain (IPR050771), the dehydrogenase E1 domain (IPR001017), and the thiamine diphosphate (ThDP)-binding domain (IPR029061). The gene is located on human chromosome 19q13.2 (OpenTargets Search: -BCKDHA).

The following table provides a summary of the key molecular, biochemical, and disease-related properties of BCKDHA:

Property	Summary
Gene name	BCKDHA (branched chain keto acid dehydrogenase E1 subunit alpha) (OpenTargets Search: -BCKDHA)
UniProt ID	P12694 (user-provided target identity)
Protein name	2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial; also called branched-chain alpha-keto acid dehydrogenase E1 component alpha chain (BCKDH E1α) (bo2024primaryrolesof pages 11-13, szabo2024mitochondrialalphaketoacid pages 6-9)
EC number	EC 1.2.4.4 (bo2024primaryrolesof pages 11-13)
Organism	Homo sapiens (human) (OpenTargets Search: -BCKDHA)
Chromosomal location	19q13.2; the gene has historically been assigned to chromosome 19q13 in human BCKDH/MSUD literature and reference databases (OpenTargets Search: -BCKDHA)
Protein length	445 aa precursor; includes an N-terminal mitochondrial targeting peptide, with a reported 27-aa targeting signal peptide for BCKDH pathway proteins in metabolon studies (patrick2022metabolonformationregulates pages 1-3)
Molecular weight	~49 kDa precursor (inferred from 445 aa sequence length; commonly reported for human BCKDHA reference entries) (user-provided target identity)
Subcellular localization	Mitochondrial matrix / mitochondrial BCKDH complex. Mitochondrial localization is supported by subcellular fractionation and overlap with MitoTracker in cardiomyocytes; BCKDH functions as a mitochondrial multienzyme complex (weiss2024mitolnccontrolscardiac pages 14-15, weiss2024mitolnccontrolscardiac pages 10-12, szabo2024mitochondrialalphaketoacid pages 6-9)
Cofactors	Thiamine pyrophosphate (TPP/ThDP) is required by the E1 component; catalysis also depends on the BCKDH multienzyme system using lipoate/lipoyl-E2, CoA, and NAD+ across E1/E2/E3 steps (mann2021branchedchainaminoacids pages 4-6, szabo2024mitochondrialalphaketoacid pages 6-9, hawes1995rolesofamino pages 4-5)
Primary biochemical function	Catalytic E1α subunit of the mitochondrial BCKDH complex, which performs the rate-limiting irreversible oxidative decarboxylation of branched-chain α-ketoacids generated from leucine, isoleucine, and valine catabolism (bo2024primaryrolesof pages 11-13, bo2024primaryrolesof pages 13-15, mann2021branchedchainaminoacids pages 4-6)
Reaction catalyzed	As part of BCKDH, converts branched-chain α-ketoacids to their corresponding branched-chain acyl-CoA derivatives with release of CO2 and production of NADH through the coupled E1/E2/E3 reaction sequence (bo2024primaryrolesof pages 11-13, szabo2024mitochondrialalphaketoacid pages 1-6, mann2021branchedchainaminoacids pages 4-6)
Complex architecture / partners	BCKDHA forms the E1 heterotetramer (α2β2) with BCKDHB (E1β); this E1 component docks to the E2 core (DBT) and works with E3 (DLD) in the mitochondrial BCKDH complex (szabo2024mitochondrialalphaketoacid pages 6-9, szabo2024mitochondrialalphaketoacid pages 9-13, szabo2024mitochondrialalphaketoacid pages 16-19)
Key regulatory site	Ser293 on BCKDHA is the canonical inhibitory phosphorylation site best supported by classic mechanistic work; phosphorylation disrupts active-site/TPP-related function and inactivates BCKDH (hawes1995rolesofamino pages 1-1, hawes1995rolesofamino pages 4-5)
Key regulators	BCKDK/BDK phosphorylates and inhibits BCKDHA; PPM1K/PP2Cm dephosphorylates and activates BCKDH. These enzymes are major determinants of tissue-specific BCAA oxidative flux (bo2024primaryrolesof pages 13-15, mann2021branchedchainaminoacids pages 9-11, szabo2024mitochondrialalphaketoacid pages 19-22)
Substrate specificity	Preferred branched-chain α-ketoacid substrates include α-ketoisovalerate (KIV, valine-derived; 100%), α-ketoisocaproate (KIC, leucine-derived; ~70%), α-keto-β-methylvalerate (KMV, isoleucine-derived; ~40%); broader activity has also been reported toward α-ketobutyrate (~50%), 4-methylthio-α-ketobutyrate (~30%), and pyruvate (~20%) in comparative analyses of E1b specificity (szabo2024mitochondrialalphaketoacid pages 1-6, mann2021branchedchainaminoacids pages 4-6)
Pathway context	BCKDHA acts after BCAT2-mediated transamination and before downstream acyl-CoA oxidation steps; BCAT2 can physically interact with BCKDH to form a metabolon that supports substrate channeling (blair2021wholebodymetabolicfate pages 3-4, mann2021branchedchainaminoacids pages 9-11, bo2024primaryrolesof pages 11-13)
Associated disease	Maple syrup urine disease (MSUD), especially type 1A, plus intermediate and intermittent MSUD forms; Open Targets shows strong disease association scores for hereditary disease and MSUD-related phenotypes (OpenTargets Search: -BCKDHA, margutti2020maplesyrupurine pages 2-4, campanholi2021molecularbasisof pages 1-2)
Representative disease features	Pathogenic BCKDHA variants reduce BCKDH activity, causing accumulation of BCAAs/BCKAs and leading to neonatal or infantile encephalopathic disease; classic MSUD is typically associated with <3% residual enzyme activity (li2023identificationofgene pages 4-6, campanholi2021molecularbasisof pages 1-2, fang2021geneticanalysisby pages 4-5)
Recent regulatory insights (2023–2024)	New work shows mitolnc can allosterically activate mitochondrial BCKDH independently of phosphorylation in heart, while BDK inhibitors lower p-BCKDHA and improve cardiometabolic phenotypes in mouse models (weiss2024mitolnccontrolscardiac pages 14-15, weiss2024mitolnccontrolscardiac pages 12-14, flach2023smallmoleculebranchedchain pages 1-2)

Table: This table summarizes the core molecular, biochemical, localization, regulatory, and disease-related properties of human BCKDHA. It is useful as a compact reference for functional annotation and interpretation of BCKDHA in BCAA metabolism and MSUD.

1. Enzymatic Function and Catalytic Mechanism

1.1 Primary Reaction

BCKDHA encodes the α-subunit of the E1 component of the mitochondrial branched-chain α-keto acid dehydrogenase (BCKDH) complex, which catalyzes the rate-limiting and irreversible step in the catabolism of the three branched-chain amino acids (BCAAs): leucine, isoleucine, and valine (bo2024primaryrolesof pages 11-13, mann2021branchedchainaminoacids pages 4-6). The overall reaction performed by the BCKDH complex is the oxidative decarboxylation of branched-chain α-keto acids (BCKAs) — the transamination products of BCAAs — to their corresponding branched-chain acyl-CoA derivatives, with the concomitant release of CO₂ and generation of NADH (bo2024primaryrolesof pages 11-13, szabo2024mitochondrialalphaketoacid pages 1-6). The three specific substrates are α-ketoisocaproate (KIC, derived from leucine), α-keto-β-methylvalerate (KMV, derived from isoleucine), and α-ketoisovalerate (KIV, derived from valine) (mann2021branchedchainaminoacids pages 4-6).

1.2 E1 Component and Thiamine Pyrophosphate Dependence

The E1 component, in which BCKDHA functions, is a heterotetramer consisting of two α-subunits (BCKDHA) and two β-subunits (BCKDHB), forming an α₂β₂ assembly with two functional active sites (bo2024primaryrolesof pages 11-13, szabo2024mitochondrialalphaketoacid pages 6-9). The E1 component requires thiamine pyrophosphate (ThDP/TPP) as an essential cofactor (mann2021branchedchainaminoacids pages 4-6, hawes1995rolesofamino pages 4-5). Structural studies have shown that ThDP adopts a characteristic "V" shape near the active sites, which are buried within the interfaces between subunits (szabo2024mitochondrialalphaketoacid pages 9-13). The pyrophosphate moiety of ThDP is coordinated by the N-terminal domain of one subunit, while the aminopyrimidine moiety is tethered by both the N-terminal and middle domains of an adjacent monomer, establishing functional coupling between subunits (szabo2024mitochondrialalphaketoacid pages 6-9). The E1α subunit provides residues critical for binding the diphosphate portion of thiamine pyrophosphate and associated divalent metal atoms, while E1β subunits contribute residues that bind the thiazolium ring portion (hawes1995rolesofamino pages 4-5).

1.3 Substrate Specificity

The BCKDH E1 component demonstrates broad substrate specificity. Comparative studies of relative maximal reaction rates show that α-ketoisovalerate (KIV) is the preferred substrate (100% relative activity), followed by α-ketoisocaproate (KIC, ~70%), α-ketobutyrate (~50%), α-keto-β-methylvalerate (KMV, ~40%), 4-methylthio-α-ketobutyrate (~30%), and pyruvate (~20%) (szabo2024mitochondrialalphaketoacid pages 1-6). This breadth of substrate acceptance distinguishes BCKDH from the related pyruvate dehydrogenase and α-ketoglutarate dehydrogenase complexes (szabo2024mitochondrialalphaketoacid pages 1-6).

1.4 Multienzyme Complex Architecture

The BCKDH complex is one of the largest multienzyme assemblies in the mitochondrial matrix, with molecular weights reaching up to ~10 million Daltons across species. It consists of three catalytically active components: E1 (the α-keto acid decarboxylase, encoded by BCKDHA and BCKDHB), E2 (dihydrolipoyl transacylase, encoded by DBT), and E3 (dihydrolipoamide dehydrogenase, encoded by DLD) (szabo2024mitochondrialalphaketoacid pages 6-9, szabo2024mitochondrialalphaketoacid pages 16-19). The E2 component serves as the structural scaffold, forming a 24-meric cubic core that anchors E1 and E3 as peripheral components. The human BCKDH complex typically contains 12 E1 heterotetramers positioned along the core edges and 6 E3 dimers on the faces of the cubic E2 core (szabo2024mitochondrialalphaketoacid pages 16-19). The three catalytic sites are connected via flexible lipoylated arms extending from the E2 core structure, which shuttle reaction intermediates between the E1, E2, and E3 active sites during the multi-step catalytic cycle (szabo2024mitochondrialalphaketoacid pages 9-13).

2. Subcellular Localization

BCKDHA is synthesized as a precursor protein containing an N-terminal mitochondrial targeting signal peptide (reported at 27 amino acids) that directs the protein to the mitochondrial matrix. Subcellular fractionation experiments and colocalization with MitoTracker Deep Red staining in isolated cardiomyocytes have confirmed that the BCKDH complex, including BCKDHA, resides in the mitochondrial matrix (weiss2024mitolnccontrolscardiac pages 14-15, weiss2024mitolnccontrolscardiac pages 10-12). RNA in situ hybridization-proximity ligation assays (rISH-PLA) have further demonstrated that BCKDHA interactions occur outside the nucleus and overlap with mitochondrial markers (weiss2024mitolnccontrolscardiac pages 10-12). The complex functions at the inner mitochondrial compartment, where BCAA catabolism generates acyl-CoA intermediates that can feed into the TCA cycle and β-oxidation pathways (bo2024primaryrolesof pages 11-13).

3. Regulatory Mechanisms

3.1 Phosphorylation-Based Regulation

The activity of the BCKDH complex is primarily controlled through reversible phosphorylation of the E1α subunit (BCKDHA) at Serine 293 (Ser293), the canonical inhibitory phosphorylation site (mann2021branchedchainaminoacids pages 9-11, hawes1995rolesofamino pages 1-1). Phosphorylation is catalyzed by branched-chain α-ketoacid dehydrogenase kinase (BCKDK/BDK), which inactivates the complex, while dephosphorylation by the mitochondrial protein phosphatase PPM1K (also known as PP2Cm) reactivates it (bo2024primaryrolesof pages 13-15, mann2021branchedchainaminoacids pages 9-11). Mutagenesis studies have revealed that phosphorylation at Ser293 disrupts the active site by placing a negatively charged phosphate group near the thiamine pyrophosphate binding domain, preventing cofactor reconstitution and abolishing enzymatic activity (hawes1995rolesofamino pages 4-5). Alanine substitution of Ser293 increases substrate Km values without affecting Vmax, indicating this residue plays a role in substrate binding rather than catalysis per se (hawes1995rolesofamino pages 4-5). A phosphomimetic S293E mutation results in complete loss of activity and failure to reconstitute with TPP (hawes1995rolesofamino pages 4-5). A second phosphorylation site at Ser303 has also been identified (mann2021branchedchainaminoacids pages 9-11).

Specific residues surrounding Ser293 are critical for kinase recognition: Arg288 is essential for BDK-mediated phosphorylation, while His292 and Asp296 are required for catalytic activity (hawes1995rolesofamino pages 1-1). Thiamine pyrophosphate inhibits phosphorylation of most E1 mutant enzymes, indicating the phosphorylation site region overlaps with the TPP binding domain (hawes1995rolesofamino pages 1-1).

3.2 Tissue-Specific Regulation

The tissue-specific expression patterns of BCKDK and PPM1K create differential BCKDH activity states across organs. Skeletal muscle expresses high levels of BCKDK but low BCKDH complex abundance, resulting in predominantly phosphorylated (inactive) BCKDH that preserves BCKAs for re-amination to BCAAs and protein synthesis (bo2024primaryrolesof pages 13-15, mann2021branchedchainaminoacids pages 9-11). Conversely, liver expresses low BCKDK levels, enabling constitutive BCKDH activation for gluconeogenesis and ketogenesis from BCAA carbon skeletons (bo2024primaryrolesof pages 13-15). PPM1K shows high expression in brain, heart, kidney, diaphragm, and liver, but lower levels in skeletal muscle, further contributing to tissue-specific BCAA catabolism patterns (bo2024primaryrolesof pages 15-16).

3.3 Allosteric Regulation and Metabolon Formation

Recent work has uncovered novel regulatory mechanisms for the BCKDH complex. Weiss et al. (2024) identified mitolnc, a nuclear-encoded long non-coding RNA localized in mitochondria, as an allosteric activator of the BCKDH complex in cardiomyocytes. Mitolnc directly interacts with BCKDHA and other BCKDH subunits, enhancing enzymatic activity independently of phosphorylation status (weiss2024mitolnccontrolscardiac pages 14-15, weiss2024mitolnccontrolscardiac pages 12-14). Loss of mitolnc reduces BCKDH complex activity in the heart, leading to accumulation of BCAAs (particularly leucine), hyperactivation of mTOR signaling, and cardiac hypertrophy (weiss2024mitolnccontrolscardiac pages 14-15, weiss2024mitolnccontrolscardiac pages 10-12). This mechanism provides an explanation for how BCKDH can maintain high activity in the heart despite relatively high BDK-mediated phosphorylation (weiss2024mitolnccontrolscardiac pages 14-15).

Additionally, BCAT2 (branched-chain aminotransferase 2) physically interacts with the BCKDH E1 subunit to form a metabolon that facilitates substrate channeling of BCKAs directly from the transamination enzyme to the decarboxylation complex (blair2021wholebodymetabolicfate pages 3-4, mann2021branchedchainaminoacids pages 9-11). BCAT2 binding to BCKDH increases decarboxylation rates, and this interaction is dynamically regulated — phosphorylation of BCKDH destabilizes the BCAT2–BCKDH association (blair2021wholebodymetabolicfate pages 3-4). Absence of BCAT2 abolishes BCKDH activity, underscoring the functional interdependence of these enzymes (bo2024primaryrolesof pages 11-13).

BCKAs themselves also participate in regulatory feedback: α-ketoisocaproate (KIC) and α-ketoisovalerate (KIV) allosterically inhibit BCKDK, thereby promoting BCKDH dephosphorylation and activation when BCKA levels are elevated (mann2021branchedchainaminoacids pages 9-11, weiss2024mitolnccontrolscardiac pages 10-12).

4. Metabolic Pathway Context

4.1 BCAA Catabolic Pathway

BCKDHA operates at the second and rate-limiting step of BCAA catabolism. The first step is the reversible transamination of BCAAs (leucine, isoleucine, valine) by branched-chain aminotransferases (BCAT1 in cytosol, BCAT2 in mitochondria) to their corresponding BCKAs, with concomitant conversion of α-ketoglutarate to glutamate (bo2024primaryrolesof pages 11-13). The BCKDH complex then performs the irreversible oxidative decarboxylation of BCKAs to branched-chain acyl-CoA intermediates (isovaleryl-CoA, α-methylbutyryl-CoA, and isobutyryl-CoA), which subsequently undergo further catabolism through pathways analogous to β-oxidation of fatty acids (bo2024primaryrolesof pages 11-13, mann2021branchedchainaminoacids pages 4-6). The downstream products ultimately include acetyl-CoA and succinyl-CoA, which feed into the TCA cycle for energy production (cai2026branchedchainaminoacid pages 3-5).

4.2 Integration with Other Metabolic Pathways

Recent research has revealed that BCKDH activity is linked to lipid metabolism through the BCKDH kinase/phosphatase system. White et al. (2018) demonstrated that the BDK and BDP (PP2Cm) integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase (ACLY), connecting BCAA catabolism to de novo lipogenesis (flach2023smallmoleculebranchedchain pages 1-2). In the heart, the major metabolic fate of BCKAs is reamination back to BCAAs rather than oxidation, partly due to low expression of the mitochondrial BCAA transporter SLC25A44 (walejko2021branchedchainαketoacidsare pages 1-2). Elevated BCKA levels activate protein synthesis pathways including 4E-BP1 and MEK-ERK signaling, contributing to pathologic cardiac hypertrophy in obesity (walejko2021branchedchainαketoacidsare pages 1-2).

5. Disease Associations

5.1 Maple Syrup Urine Disease (MSUD)

The primary Mendelian disease caused by BCKDHA mutations is maple syrup urine disease type 1A (MSUD; OMIM #608348), an autosomal recessive inborn error of metabolism. MSUD results from deficient BCKDH complex activity, leading to toxic accumulation of BCAAs and their corresponding BCKAs in blood and tissues (margutti2020maplesyrupurine pages 2-4, campanholi2021molecularbasisof pages 1-2). OpenTargets data confirm strong disease-target association scores (0.84–0.87) for BCKDHA with MSUD and hereditary disease categories (OpenTargets Search: -BCKDHA).

MSUD is classified into several clinical subtypes based on residual enzyme activity and disease severity: classic (the most severe form with <3% residual activity, presenting in the neonatal period), intermediate, intermittent, and thiamine-responsive forms (campanholi2021molecularbasisof pages 1-2). Classic MSUD typically presents within the first two weeks of life with poor feeding, vomiting, lethargy, seizures, hypotonia, and a characteristic maple syrup odor in urine, and can progress to encephalopathy and death if untreated (li2023identificationofgene pages 4-6, sun2020identificationofeight pages 4-5). Multiple types of pathogenic BCKDHA mutations have been identified, including missense, nonsense, frameshift, and splice-site mutations (margutti2020maplesyrupurine pages 2-4, sun2020identificationofeight pages 4-5). Structurally, many disease-causing missense mutations alter protein conformation; for example, the p.Gly281Arg mutation causes steric hindrance altering the β-turn conformation, while the p.A220V mutation changes the side chain structure (li2023identificationofgene pages 4-6, fang2021geneticanalysisby pages 4-5). No clear genotype-phenotype correlations have been established, although mutations within functional domains may lead to more severe disease (margutti2020maplesyrupurine pages 2-4, campanholi2021molecularbasisof pages 1-2).

5.2 Cardiometabolic Disease

Impaired BCKDH activity is implicated in cardiovascular disease. In dilated cardiomyopathy, cardiac BCAA levels are elevated with decreased mitochondrial BCAT2 and BCKDH expression (du2022theroleof pages 6-7). BDK inhibitors such as BT2 and PF-07208254 have shown therapeutic promise by reducing phosphorylated BCKDHA levels, lowering circulating BCAAs and BCKAs, and improving cardiac function (fractional shortening and ejection fraction) in mouse models of heart failure induced by transverse aortic constriction (flach2023smallmoleculebranchedchain pages 1-2, du2022theroleof pages 6-7). BT2 promotes BCKDH dephosphorylation and activation by causing dissociation of BCKDK from the BCKDH complex (du2022theroleof pages 6-7).

5.3 Cancer

BCAA metabolic reprogramming involving BCKDHA is increasingly recognized in oncology. In pancreatic ductal adenocarcinoma (PDAC), BCKDHA is significantly upregulated compared to normal pancreatic cells, and its knockdown selectively impairs tumor growth by inhibiting fatty acid synthesis while maintaining TCA cycle function, indicating that PDAC utilizes BCAA-derived carbon specifically for lipogenesis to support proliferation (cai2026branchedchainaminoacid pages 5-7). In triple-negative breast cancer (TNBC), the relationship is inverse: high BCKDK expression (indicating suppressed BCKDH activity) correlates with worse relapse-free survival and increased aggressiveness, while high BCKDH phosphatase activity correlates with better outcomes (cai2026branchedchainaminoacid pages 5-7). Elevated BCKDK expression has also been observed in hepatocellular carcinoma, promoting metastasis through ERK signaling (li2025proteinlipoylationin pages 3-4, cai2026branchedchainaminoacid pages 27-28). These findings highlight the tumor type-specific heterogeneity in BCAA metabolic reprogramming, with some cancers increasing BCKDH activity for energy and biosynthetic precursors and others suppressing it to accumulate BCAAs for sustained mTORC1 signaling (cai2026branchedchainaminoacid pages 3-5).

5.4 Diabetes and Metabolic Syndrome

Elevated circulating BCAAs are consistently associated with insulin resistance and type 2 diabetes (wang2025multiplerolesof pages 1-2). Zhou et al. (2024) demonstrated that hepatic BCKDK promotes gluconeogenesis through CREB and FOXO1 signaling pathways independently of BCKDHA-mediated BCAA catabolism, as liver-specific BCKDHA knockout mice displayed normal glucose tolerance, while BCKDK knockout inhibited hepatic glucose production (flach2023smallmoleculebranchedchain pages 1-2). This finding separates the kinase's metabolic regulatory role from its canonical function of BCKDH phosphorylation.

6. Summary

BCKDHA encodes the catalytic E1α subunit of the mitochondrial BCKDH complex, the rate-limiting enzyme in branched-chain amino acid catabolism. As a thiamine pyrophosphate-dependent decarboxylase, it forms a heterotetrameric E1 component (α₂β₂) with BCKDHB that initiates the irreversible oxidative decarboxylation of BCKAs derived from leucine, isoleucine, and valine. The enzyme functions within the mitochondrial matrix as part of a massive multienzyme complex organized around a 24-meric E2 core. Its activity is tightly regulated by reversible phosphorylation at Ser293 (by BCKDK and PPM1K), by allosteric mechanisms including a recently discovered lncRNA activator (mitolnc), and by metabolon formation with the upstream enzyme BCAT2. Deficiency due to BCKDHA mutations causes maple syrup urine disease, while dysregulated BCKDH activity is increasingly implicated in cancer, cardiovascular disease, and metabolic syndrome, making it an emerging therapeutic target.

References

(OpenTargets Search: -BCKDHA): Open Targets Query (-BCKDHA, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(bo2024primaryrolesof pages 11-13): Tomoki Bo and Junichi Fujii. Primary roles of branched chain amino acids (bcaas) and their metabolism in physiology and metabolic disorders. Molecules, 30:56, Dec 2024. URL: https://doi.org/10.3390/molecules30010056, doi:10.3390/molecules30010056. This article has 61 citations.
(szabo2024mitochondrialalphaketoacid pages 6-9): Eszter Szabó, Bálint Nagy, András Czajlik, T. Komlódi, Olivér Ozohanics, László Tretter, and A. Ambrus. Mitochondrial alpha-keto acid dehydrogenase complexes: recent developments on structure and function in health and disease. Sub-cellular biochemistry, 104:295-381, 2024. URL: https://doi.org/10.1007/978-3-031-58843-3_13, doi:10.1007/978-3-031-58843-3_13. This article has 16 citations.
(patrick2022metabolonformationregulates pages 1-3): McKenzie Patrick, Zhimin Gu, Gen Zhang, R. Max Wynn, Pranita Kaphle, Hui Cao, Hieu Vu, Feng Cai, Xiaofei Gao, Yuannyu Zhang, Mingyi Chen, Min Ni, David T. Chuang, Ralph J. DeBerardinis, and Jian Xu. Metabolon formation regulates branched-chain amino acid oxidation and homeostasis. Nature Metabolism, 4:1775-1791, Nov 2022. URL: https://doi.org/10.1038/s42255-022-00689-4, doi:10.1038/s42255-022-00689-4. This article has 51 citations and is from a domain leading peer-reviewed journal.
(weiss2024mitolnccontrolscardiac pages 14-15): Maria Weiss, Sara Hettrich, Theresa Hofmann, Salma Hachim, Stefan Günther, Thomas Braun, and Thomas Boettger. Mitolnc controls cardiac bcaa metabolism and heart hypertrophy by allosteric activation of bckdh. Nucleic Acids Research, 52:6629-6646, Apr 2024. URL: https://doi.org/10.1093/nar/gkae226, doi:10.1093/nar/gkae226. This article has 11 citations and is from a highest quality peer-reviewed journal.
(weiss2024mitolnccontrolscardiac pages 10-12): Maria Weiss, Sara Hettrich, Theresa Hofmann, Salma Hachim, Stefan Günther, Thomas Braun, and Thomas Boettger. Mitolnc controls cardiac bcaa metabolism and heart hypertrophy by allosteric activation of bckdh. Nucleic Acids Research, 52:6629-6646, Apr 2024. URL: https://doi.org/10.1093/nar/gkae226, doi:10.1093/nar/gkae226. This article has 11 citations and is from a highest quality peer-reviewed journal.
(mann2021branchedchainaminoacids pages 4-6): Gagandeep Mann, Stephen Mora, Glory Madu, and Olasunkanmi A. J. Adegoke. Branched-chain amino acids: catabolism in skeletal muscle and implications for muscle and whole-body metabolism. Frontiers in Physiology, Jul 2021. URL: https://doi.org/10.3389/fphys.2021.702826, doi:10.3389/fphys.2021.702826. This article has 312 citations.
(hawes1995rolesofamino pages 4-5): John W. Hawes, R. Jason Schnepf, Anne E. Jenkins, Yoshiharu Shimomura, Kirill M. Popov, and Robert A. Harris. Roles of amino acid residues surrounding phosphorylation site 1 of branched-chain α-ketoacid dehydrogenase (bckdh) in catalysis and phosphorylation site recognition by bckdh kinase. Journal of Biological Chemistry, 270(52):31071-31076, Dec 1995. URL: https://doi.org/10.1074/jbc.270.52.31071, doi:10.1074/jbc.270.52.31071. This article has 32 citations and is from a domain leading peer-reviewed journal.
(bo2024primaryrolesof pages 13-15): Tomoki Bo and Junichi Fujii. Primary roles of branched chain amino acids (bcaas) and their metabolism in physiology and metabolic disorders. Molecules, 30:56, Dec 2024. URL: https://doi.org/10.3390/molecules30010056, doi:10.3390/molecules30010056. This article has 61 citations.
(szabo2024mitochondrialalphaketoacid pages 1-6): Eszter Szabó, Bálint Nagy, András Czajlik, T. Komlódi, Olivér Ozohanics, László Tretter, and A. Ambrus. Mitochondrial alpha-keto acid dehydrogenase complexes: recent developments on structure and function in health and disease. Sub-cellular biochemistry, 104:295-381, 2024. URL: https://doi.org/10.1007/978-3-031-58843-3_13, doi:10.1007/978-3-031-58843-3_13. This article has 16 citations.
(szabo2024mitochondrialalphaketoacid pages 9-13): Eszter Szabó, Bálint Nagy, András Czajlik, T. Komlódi, Olivér Ozohanics, László Tretter, and A. Ambrus. Mitochondrial alpha-keto acid dehydrogenase complexes: recent developments on structure and function in health and disease. Sub-cellular biochemistry, 104:295-381, 2024. URL: https://doi.org/10.1007/978-3-031-58843-3_13, doi:10.1007/978-3-031-58843-3_13. This article has 16 citations.
(szabo2024mitochondrialalphaketoacid pages 16-19): Eszter Szabó, Bálint Nagy, András Czajlik, T. Komlódi, Olivér Ozohanics, László Tretter, and A. Ambrus. Mitochondrial alpha-keto acid dehydrogenase complexes: recent developments on structure and function in health and disease. Sub-cellular biochemistry, 104:295-381, 2024. URL: https://doi.org/10.1007/978-3-031-58843-3_13, doi:10.1007/978-3-031-58843-3_13. This article has 16 citations.
(hawes1995rolesofamino pages 1-1): John W. Hawes, R. Jason Schnepf, Anne E. Jenkins, Yoshiharu Shimomura, Kirill M. Popov, and Robert A. Harris. Roles of amino acid residues surrounding phosphorylation site 1 of branched-chain α-ketoacid dehydrogenase (bckdh) in catalysis and phosphorylation site recognition by bckdh kinase. Journal of Biological Chemistry, 270(52):31071-31076, Dec 1995. URL: https://doi.org/10.1074/jbc.270.52.31071, doi:10.1074/jbc.270.52.31071. This article has 32 citations and is from a domain leading peer-reviewed journal.
(mann2021branchedchainaminoacids pages 9-11): Gagandeep Mann, Stephen Mora, Glory Madu, and Olasunkanmi A. J. Adegoke. Branched-chain amino acids: catabolism in skeletal muscle and implications for muscle and whole-body metabolism. Frontiers in Physiology, Jul 2021. URL: https://doi.org/10.3389/fphys.2021.702826, doi:10.3389/fphys.2021.702826. This article has 312 citations.
(szabo2024mitochondrialalphaketoacid pages 19-22): Eszter Szabó, Bálint Nagy, András Czajlik, T. Komlódi, Olivér Ozohanics, László Tretter, and A. Ambrus. Mitochondrial alpha-keto acid dehydrogenase complexes: recent developments on structure and function in health and disease. Sub-cellular biochemistry, 104:295-381, 2024. URL: https://doi.org/10.1007/978-3-031-58843-3_13, doi:10.1007/978-3-031-58843-3_13. This article has 16 citations.
(blair2021wholebodymetabolicfate pages 3-4): Megan C. Blair, Michael D. Neinast, and Zoltan Arany. Whole-body metabolic fate of branched-chain amino acids. The Biochemical journal, 478 4:765-776, Feb 2021. URL: https://doi.org/10.1042/bcj20200686, doi:10.1042/bcj20200686. This article has 45 citations.
(margutti2020maplesyrupurine pages 2-4): Ana Vitoria Barban Margutti, Wilson Araújo Silva, Daniel Fantozzi Garcia, Greice Andreotti de Molfetta, Adriana Aparecida Marques, Tatiana Amorim, Vânia Mesquita Gadelha Prazeres, Raquel Tavares Boy da Silva, Irene Kazue Miura, João Seda Neto, Emerson de Santana Santos, Mara Lúcia Schmitz Ferreira Santos, Charles Marques Lourenço, Tássia Tonon, Fernanda Sperb-Ludwig, Carolina Fischinger Moura de Souza, Ida Vanessa Döederlein Schwartz, and José Simon Camelo. Maple syrup urine disease in brazilian patients: variants and clinical phenotype heterogeneity. Orphanet Journal of Rare Diseases, Nov 2020. URL: https://doi.org/10.1186/s13023-020-01590-7, doi:10.1186/s13023-020-01590-7. This article has 18 citations and is from a peer-reviewed journal.
(campanholi2021molecularbasisof pages 1-2): Diana Ruffato Resende Campanholi, Ana Vitoria Barban Margutti, Wilson A. Silva, Daniel F. Garcia, Greice A. Molfetta, Adriana A. Marques, Ida Vanessa Döederlein Schwartz, V. Cornejo, Valerie Hamilton, Gabriela Castro, Fernanda Sperb‐Ludwig, Ester S. Borges, and José S. Camelo. Molecular basis of various forms of maple syrup urine disease in chilean patients. Molecular Genetics & Genomic Medicine, May 2021. URL: https://doi.org/10.1002/mgg3.1616, doi:10.1002/mgg3.1616. This article has 10 citations and is from a peer-reviewed journal.
(li2023identificationofgene pages 4-6): Lulu Li, Xinmei Mao, Nan Yang, Taoyun Ji, Shunan Wang, Yulan Ma, Haihe Yang, Yuting Sang, Jinqi Zhao, Lifei Gong, Yue Tang, and Yuanyuan Kong. Identification of gene mutations in six chinese patients with maple syrup urine disease. Frontiers in Genetics, Feb 2023. URL: https://doi.org/10.3389/fgene.2023.1132364, doi:10.3389/fgene.2023.1132364. This article has 8 citations and is from a peer-reviewed journal.
(fang2021geneticanalysisby pages 4-5): Xiaohua Fang, Xiaofan Zhu, Yin Feng, Ying Bai, Xuechao Zhao, Ning Liu, and Xiangdong Kong. Genetic analysis by targeted next-generation sequencing and novel variation identification of maple syrup urine disease in chinese han population. Scientific Reports, Sep 2021. URL: https://doi.org/10.1038/s41598-021-98357-2, doi:10.1038/s41598-021-98357-2. This article has 10 citations and is from a peer-reviewed journal.
(weiss2024mitolnccontrolscardiac pages 12-14): Maria Weiss, Sara Hettrich, Theresa Hofmann, Salma Hachim, Stefan Günther, Thomas Braun, and Thomas Boettger. Mitolnc controls cardiac bcaa metabolism and heart hypertrophy by allosteric activation of bckdh. Nucleic Acids Research, 52:6629-6646, Apr 2024. URL: https://doi.org/10.1093/nar/gkae226, doi:10.1093/nar/gkae226. This article has 11 citations and is from a highest quality peer-reviewed journal.
(flach2023smallmoleculebranchedchain pages 1-2): Rachel J. Roth Flach, Eliza Bollinger, Allan R. Reyes, Brigitte Laforest, Bethany L. Kormos, Shenping Liu, Matthew R. Reese, Luis A. Martinez Alsina, Leanne Buzon, Yuan Zhang, Bruce Bechle, Amy Rosado, Parag V. Sahasrabudhe, John Knafels, Samit K. Bhattacharya, Kiyoyuki Omoto, John C. Stansfield, Liam D. Hurley, LouJin Song, Lina Luo, Susanne B. Breitkopf, Mara Monetti, Teresa Cunio, Brendan Tierney, Frank J. Geoly, Jake Delmore, C. Parker Siddall, Liang Xue, Ka N. Yip, Amit S. Kalgutkar, Russell A. Miller, Bei B. Zhang, and Kevin J. Filipski. Small molecule branched-chain ketoacid dehydrogenase kinase (bdk) inhibitors with opposing effects on bdk protein levels. Nature Communications, Aug 2023. URL: https://doi.org/10.1038/s41467-023-40536-y, doi:10.1038/s41467-023-40536-y. This article has 38 citations and is from a highest quality peer-reviewed journal.
(bo2024primaryrolesof pages 15-16): Tomoki Bo and Junichi Fujii. Primary roles of branched chain amino acids (bcaas) and their metabolism in physiology and metabolic disorders. Molecules, 30:56, Dec 2024. URL: https://doi.org/10.3390/molecules30010056, doi:10.3390/molecules30010056. This article has 61 citations.
(cai2026branchedchainaminoacid pages 3-5): Dongchi Cai, Jialin Ji, Chunhui Yang, and Hong Cai. Branched-chain amino acid metabolic reprogramming and cancer: molecular mechanisms, immune regulation, and precision targeting. Oncology Research, 34(1):1-10, Jan 2026. URL: https://doi.org/10.32604/or.2025.071152, doi:10.32604/or.2025.071152. This article has 6 citations and is from a peer-reviewed journal.
(walejko2021branchedchainαketoacidsare pages 1-2): Jacquelyn M. Walejko, Bridgette A. Christopher, Scott B. Crown, Guo-Fang Zhang, Adrian Pickar-Oliver, Takeshi Yoneshiro, Matthew W. Foster, Stephani Page, Stephan van Vliet, Olga Ilkayeva, Michael J. Muehlbauer, Matthew W. Carson, Joseph T. Brozinick, Craig D. Hammond, Ruth E. Gimeno, M. Arthur Moseley, Shingo Kajimura, Charles A. Gersbach, Christopher B. Newgard, Phillip J. White, and Robert W. McGarrah. Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart. Nature Communications, Mar 2021. URL: https://doi.org/10.1038/s41467-021-21962-2, doi:10.1038/s41467-021-21962-2. This article has 112 citations and is from a highest quality peer-reviewed journal.
(sun2020identificationofeight pages 4-5): Wei-Hua Sun, Bing-Bing Wu, Ya-Qiong Wang, Meng-Yuan Wu, Xin-Ran Dong, Yue-Ping Zhang, Wei Lu, Ping Zhang, Bin Yang, Min Zhang, Hong-Jiang Wu, and Wen-Hao Zhou. Identification of eight novel mutations in 11 chinese patients with maple syrup urine disease. World Journal of Pediatrics, pages 1-10, Mar 2020. URL: https://doi.org/10.1007/s12519-020-00349-1, doi:10.1007/s12519-020-00349-1. This article has 12 citations and is from a peer-reviewed journal.
(du2022theroleof pages 6-7): Chuang Du, Wen-Jie Liu, Jing Yang, Shan-Shan Zhao, and Hui-Xin Liu. The role of branched-chain amino acids and branched-chain α-keto acid dehydrogenase kinase in metabolic disorders. Frontiers in Nutrition, Jul 2022. URL: https://doi.org/10.3389/fnut.2022.932670, doi:10.3389/fnut.2022.932670. This article has 98 citations.
(cai2026branchedchainaminoacid pages 5-7): Dongchi Cai, Jialin Ji, Chunhui Yang, and Hong Cai. Branched-chain amino acid metabolic reprogramming and cancer: molecular mechanisms, immune regulation, and precision targeting. Oncology Research, 34(1):1-10, Jan 2026. URL: https://doi.org/10.32604/or.2025.071152, doi:10.32604/or.2025.071152. This article has 6 citations and is from a peer-reviewed journal.
(li2025proteinlipoylationin pages 3-4): Sainan Li, Yingchao Liu, Wanye Hu, Aoli Deng, Xueying Ren, Lulu Chen, Yajuan Lu, Yunyi Wu, Hangqi Huang, Jinghao Cao, Jing Du, Jun Xia, and Yanchun Li. Protein lipoylation in cancer: metabolic reprogramming and therapeutic potential. Cell Death Discovery, Sep 2025. URL: https://doi.org/10.1038/s41420-025-02718-z, doi:10.1038/s41420-025-02718-z. This article has 12 citations and is from a peer-reviewed journal.
(cai2026branchedchainaminoacid pages 27-28): Dongchi Cai, Jialin Ji, Chunhui Yang, and Hong Cai. Branched-chain amino acid metabolic reprogramming and cancer: molecular mechanisms, immune regulation, and precision targeting. Oncology Research, 34(1):1-10, Jan 2026. URL: https://doi.org/10.32604/or.2025.071152, doi:10.32604/or.2025.071152. This article has 6 citations and is from a peer-reviewed journal.
(wang2025multiplerolesof pages 1-2): Lin Wang, Feng Shi, Ya Cao, and Longlong Xie. Multiple roles of branched-chain amino acid metabolism in tumour progression. Journal of Biomedical Science, Apr 2025. URL: https://doi.org/10.1186/s12929-025-01132-y, doi:10.1186/s12929-025-01132-y. This article has 13 citations and is from a domain leading peer-reviewed journal.

Artifacts

Edison artifact artifact-00

Citations

bo2024primaryrolesof pages 11-13
patrick2022metabolonformationregulates pages 1-3
mann2021branchedchainaminoacids pages 4-6
szabo2024mitochondrialalphaketoacid pages 9-13
szabo2024mitochondrialalphaketoacid pages 6-9
hawes1995rolesofamino pages 4-5
szabo2024mitochondrialalphaketoacid pages 1-6
szabo2024mitochondrialalphaketoacid pages 16-19
weiss2024mitolnccontrolscardiac pages 10-12
mann2021branchedchainaminoacids pages 9-11
hawes1995rolesofamino pages 1-1
bo2024primaryrolesof pages 13-15
bo2024primaryrolesof pages 15-16
weiss2024mitolnccontrolscardiac pages 14-15
blair2021wholebodymetabolicfate pages 3-4
cai2026branchedchainaminoacid pages 3-5
flach2023smallmoleculebranchedchain pages 1-2
campanholi2021molecularbasisof pages 1-2
du2022theroleof pages 6-7
cai2026branchedchainaminoacid pages 5-7
wang2025multiplerolesof pages 1-2
szabo2024mitochondrialalphaketoacid pages 19-22
margutti2020maplesyrupurine pages 2-4
li2023identificationofgene pages 4-6
fang2021geneticanalysisby pages 4-5
weiss2024mitolnccontrolscardiac pages 12-14
sun2020identificationofeight pages 4-5
li2025proteinlipoylationin pages 3-4
cai2026branchedchainaminoacid pages 27-28
https://doi.org/10.3390/molecules30010056,
https://doi.org/10.1007/978-3-031-58843-3_13,
https://doi.org/10.1038/s42255-022-00689-4,
https://doi.org/10.1093/nar/gkae226,
https://doi.org/10.3389/fphys.2021.702826,
https://doi.org/10.1074/jbc.270.52.31071,
https://doi.org/10.1042/bcj20200686,
https://doi.org/10.1186/s13023-020-01590-7,
https://doi.org/10.1002/mgg3.1616,
https://doi.org/10.3389/fgene.2023.1132364,
https://doi.org/10.1038/s41598-021-98357-2,
https://doi.org/10.1038/s41467-023-40536-y,
https://doi.org/10.32604/or.2025.071152,
https://doi.org/10.1038/s41467-021-21962-2,
https://doi.org/10.1007/s12519-020-00349-1,
https://doi.org/10.3389/fnut.2022.932670,
https://doi.org/10.1038/s41420-025-02718-z,
https://doi.org/10.1186/s12929-025-01132-y,

📚 Additional Documentation

Notes

(BCKDHA-notes.md)

BCKDHA (P12694) review notes

Summary of verified biology

BCKDHA encodes the E1 alpha (E1α) subunit of the mitochondrial branched-chain
alpha-ketoacid dehydrogenase (BCKDH / BCKD / BCKDC) complex. Together with BCKDHB
(E1β) it forms the α2β2 heterotetrameric E1 decarboxylase component (the
"branched-chain alpha-keto acid decarboxylase"). The complete complex is organized
around the E2 (DBT) 24-meric transacylase core, to which multiple E1 (α2β2) and E3
(DLD dimer) copies bind.

The BCKD complex catalyzes the first, committed, rate-limiting and irreversible
step of branched-chain amino acid (BCAA: leucine, isoleucine, valine) catabolism:
oxidative decarboxylation of the branched-chain 2-oxo (α-keto) acids (KIC, KMV/KMVA,
KIV — from the BCAAs via BCAT2) to branched-chain acyl-CoA + CO2.
E1 (BCKDHA + BCKDHB) catalyzes the first two half-reactions: (1) TPP-dependent
decarboxylation of the α-ketoacid, and (2) reductive acylation transferring the acyl
group to the lipoyl domain of E2. EC 1.2.4.4.
Cofactors: thiamine diphosphate (TPP/ThDP) and Mg2+; also structural K+ ions.
TPP and Mg2+ binding residues are on E1α (UniProt BINDING features: TPP at
158,159,207,239,240,265,336; Mg2+ at 238,267,269).
Localization: mitochondrial matrix (cleaved transit peptide 1–45; chain 46–445).
Regulation: phosphorylated at Ser337 (mature numbering; Ser292-alpha in structural
papers) by BCKDK (inactivating) and dephosphorylated by PPM1K (activating). Phospho of
the E1α phosphorylation loop shuts off reductive acylation, inactivating BCKDC.
Disease: biallelic loss-of-function BCKDHA variants cause Maple Syrup Urine
Disease type IA (MSUD1A, MIM:248600) — autosomal recessive. Classic MSUD has <2–5%
residual activity. Founder Y438N (a.k.a. Y393N mature numbering) mutation common in Old
Order Mennonites (incidence ~1:150 vs ~1:225,000 global).

Key evidence / provenance

UniProt P12694 (ODBA_HUMAN): FUNCTION, CATALYTIC ACTIVITY (EC 1.2.4.4; RHEA:13457
primary reaction), COFACTOR (TPP, Mg2+), SUBUNIT (α2β2; complex organized on E2 core;
interacts with PPM1K), SUBCELLULAR LOCATION (mitochondrion matrix), DISEASE (MSUD1A),
numerous MSUD variants each annotated "loss of 3-methyl-2-oxobutanoate dehydrogenase
activity". [file:human/BCKDHA/BCKDHA-uniprot.txt]
PMID:10745006 (Aevarsson 2000, Structure): crystal structure of human E1
(α2β2 heterotetramer) in complex with BCKDHB, TPP, K+, Mg2+; molecular basis of MSUD.
"the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain
alpha-ketoacid dehydrogenase multienzyme complex". Abstract-only cache.
PMID:9582350 (Wynn 1998, JBC): E1 decarboxylase = two E1α + two E1β forming α2β2
tetramer; MSUD type IA affects E1α causing loss of E1 and BCKAD catalytic activities;
E1α missense mutations impair assembly. Abstract-only.
PMID:7883996 (Chuang 1995, JCI): intermediate MSUD; G245R and F364C E1α mutations
disrupt E1 heterotetrameric assembly and function of the BCKAD complex. Abstract-only.
PMID:3593587 (Ono 1987): purification/characterization of human liver BCKADH complex;
oxidizes KIV, KIC, KMV. Abstract-only. (ComplexPortal + FlyBase source for several anns.)
PMID:12902323 / 15166214 / 15576032 (Chuang lab): structural/mechanistic studies of
human E1b (decarboxylation, reductive acylation, ThDP binding, phosphorylation-loop
regulation). GOA lists these as IPI protein binding with WITH/FROM = UniProtKB:P21953
(BCKDHB) — i.e., the E1α–E1β interaction. Abstract-only.
PMID:28514442 (BioPlex 2.0) / 33961781 (BioPlex 3.0): large-scale AP-MS interactome
screens; source of IPI protein binding (WITH/FROM P21953). Guilt-by-association scale.
PMID:11839747 (Chang 2002): NMR of the E2 lipoyl-bearing domain of the human BCKD
complex. TAS source for carboxy-lyase activity + mitochondrion.
PMID:20833797 (Zhao 2011) HDA / PMID:34800366 HTP: mitochondrial proteome/phosphoproteome
localization evidence.
dismech Maple_Syrup_Urine_Disease.yaml (MONDO:0009563): confirms BCKDH complex
(BCKDHA/BCKDHB/DBT/DLD) deficiency, first irreversible step of BCAA catabolism in mito
matrix, regulation by BCKDK/PPM1K, Type IA = E1-alpha (BCKDHA); Mennonite Y438N founder.

Curation decisions (policy-guided)

MF core: GO:0003863 branched-chain 2-oxo acid dehydrogenase activity (the E1α
decarboxylase MF). GOA has this as IDA (contributes_to and enables), IEA (EC/RHEA).
Bare protein binding (GO:0005515) IPIs: all WITH/FROM = BCKDHB. Per policy MARK these
as over-annotated (uninformative MF), not REMOVE. The biologically meaningful content
(α2β2 heterotetramer) is captured by GO:0160157 complex membership + core_functions.
IEA GO:0016624 (oxidoreductase ...disulfide as acceptor) is an InterPro2GO mapping — E1
does NOT use a disulfide acceptor (that is E3/DLD); the acceptor for E1 is the lipoyl-
lysine of E2. Too general/imprecise for E1α → MODIFY toward GO:0003863.
GO:0016831 carboxy-lyase activity (TAS): correct but generic parent of the specific
decarboxylase activity → MARK_AS_OVER_ANNOTATED / could MODIFY to GO:0003863.
No falcon deep-research file available at time of writing (recipe launched; polled).

📄 View Raw YAML

id: P12694
gene_symbol: BCKDHA
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: |-
  BCKDHA encodes the E1 alpha (E1a) subunit of the mitochondrial branched-chain
  alpha-ketoacid dehydrogenase (BCKDH/BCKD/BCKDC) complex. Together with the E1 beta
  subunit (BCKDHB) it assembles into an alpha2-beta2 heterotetrameric E1 component,
  the branched-chain 2-oxo acid decarboxylase. This E1 component associates with the
  dihydrolipoyl transacylase E2 core (DBT), which forms a 24-meric cubic scaffold,
  and with the dihydrolipoamide dehydrogenase E3 (DLD) to build the complete BCKDH
  multienzyme complex in the mitochondrial matrix. The complex catalyzes the first,
  committed, rate-limiting and irreversible step of branched-chain amino acid (BCAA;
  leucine, isoleucine, valine) catabolism, namely the oxidative decarboxylation of the
  branched-chain 2-oxo (alpha-keto) acids (4-methyl-2-oxopentanoate/KIC from leucine,
  (S)-3-methyl-2-oxopentanoate/KMV from isoleucine, and 3-methyl-2-oxobutanoate/KIV
  from valine) to their branched-chain acyl-CoA derivatives, releasing CO2 and generating
  NADH through the coupled E1/E2/E3 reaction sequence. E1a specifically carries out
  the thiamine-diphosphate (TPP)-dependent decarboxylation of the 2-oxo acid and then
  the reductive acylation that transfers the acyl group to the lipoyl-lysine of the
  E2 component (EC 1.2.4.4). Catalysis requires thiamine diphosphate and Mg2+ as cofactors,
  with structural K+ ions; the TPP/Mg2+ binding residues reside on the E1a subunit.
  BCKDH activity is controlled by reversible phosphorylation of E1a (Ser337 in mature
  human numbering) by the kinase BCKDK (inactivating) and dephosphorylation by the
  phosphatase PPM1K/PP2Cm (activating). Biallelic loss-of-function variants in BCKDHA
  cause maple syrup urine disease type IA (MSUD1A), an autosomal recessive inborn error
  of metabolism.
alternative_products:
- name: '1'
  id: P12694-1
- name: '2'
  id: P12694-2
  sequence_note: VSP_056156, VSP_056157
existing_annotations:
- term:
    id: GO:0009083
    label: branched-chain amino acid catabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: Phylogenetically-inferred involvement of the E1-alpha subunit in branched-chain
      amino acid catabolism. This is the core biological process for BCKDHA and is
      well supported by biochemistry across orthologs; the IBA is at an appropriate
      level of specificity.
    action: ACCEPT
    reason: BCKDHA is the E1-alpha subunit of the BCKDH complex, which performs the
      committed rate-limiting step of BCAA (leucine/isoleucine/valine) catabolism.
      Directly supported by biochemistry of the purified human complex and by MSUD
      disease biology.
    supported_by:
    - reference_id: PMID:3593587
      supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding
        apparent Km values in the range of 14-17 microM for those alpha-keto acids.
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: part_of
  review:
    summary: Phylogenetically-inferred membership of E1-alpha in the branched-chain
      alpha-ketoacid dehydrogenase complex. Correct and well supported; E1-alpha (with
      E1-beta) forms the E1 heterotetramer that is part of the complete BCKDH complex
      assembled on the E2/DBT core.
    action: ACCEPT
    reason: The alpha2-beta2 E1 heterotetramer is an integral part of the BCKDH complex,
      demonstrated structurally and biochemically for the human enzyme.
    supported_by:
    - reference_id: PMID:10745006
      supporting_text: the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of
        the branched-chain alpha-ketoacid dehydrogenase multienzyme complex
- term:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: Electronic annotation of the E1 branched-chain 2-oxo acid dehydrogenase
      activity (EC 1.2.4.4; RHEA:13457, RHEA:84639, RHEA:84643), corresponding to
      the specific molecular function of the BCKDH E1 component and matching the UniProt
      catalytic activity reactions. This is the correct core molecular function.
    action: ACCEPT
    reason: The IEA (EC/RHEA-mapped) term precisely matches the reaction catalyzed
      by the E1 component to which E1-alpha contributes; it is corroborated by experimental
      IDA annotations to the same term.
    supported_by:
    - reference_id: PMID:3593587
      supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding
        apparent Km values in the range of 14-17 microM for those alpha-keto acids.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: Electronic mapping from the UniProt subcellular location keyword (mitochondrion
      matrix). Correct; the mature protein is imported into the mitochondrial matrix
      after cleavage of its N-terminal transit peptide, where the BCKDH complex functions.
    action: ACCEPT
    reason: Mitochondrial matrix localization is directly established by the crystal
      structure/UniProt subcellular location and consistent with the presence of a
      cleavable mitochondrial transit peptide (residues 1-45).
    supported_by:
    - reference_id: PMID:10745006
      supporting_text: the branched-chain alpha-ketoacid dehydrogenase multienzyme
        complex
- term:
    id: GO:0016624
    label: oxidoreductase activity, acting on the aldehyde or oxo group of donors,
      disulfide as acceptor
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: InterPro2GO (IPR001017, DH_E1) electronic mapping to the parent oxidoreductase
      term. GO:0016624 is the direct is_a parent of the specific BCKDH E1 activity
      GO:0003863, so it is not wrong, but it is unnecessarily general for E1-alpha
      given that the specific decarboxylase function is already annotated.
    action: MODIFY
    reason: The annotation is a legitimate but overly broad electronic parent term.
      The specific molecular function GO:0003863 (branched-chain 2-oxo acid dehydrogenase
      activity), which is_a GO:0016624, is already supported by experimental (IDA)
      and EC/RHEA (IEA) evidence and should be used instead.
    proposed_replacement_terms:
    - id: GO:0003863
      label: branched-chain 2-oxo acid dehydrogenase activity
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:12902323
  qualifier: enables
  review:
    summary: Bare protein binding IPI with WITH/FROM = UniProtKB:P21953 (BCKDHB),
      i.e. the physiological E1-alpha/E1-beta interaction underlying the alpha2-beta2
      heterotetramer. The interaction itself is real and central, but the GO term
      protein binding is uninformative and does not convey the functional relationship.
    action: MARK_AS_OVER_ANNOTATED
    reason: Per curation guidelines, bare protein binding is uninformative. The biologically
      meaningful content (E1-alpha/E1-beta heterotetramer) is captured by the complex-membership
      annotation GO:0160157 and by core_functions; this IPI adds no functional specificity.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15166214
  qualifier: enables
  review:
    summary: Bare protein binding IPI with WITH/FROM = UniProtKB:P21953 (BCKDHB) from
      a mechanistic study of the human E1b decarboxylase (thiamine diphosphate binding
      / phosphorylation-loop conformation), i.e. again the E1-alpha/E1-beta interaction.
    action: MARK_AS_OVER_ANNOTATED
    reason: The underlying E1-alpha/E1-beta interaction is genuine but the protein
      binding term is uninformative; the heterotetramer is already represented by
      GO:0160157 complex membership and core_functions.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:15576032
  qualifier: enables
  review:
    summary: Bare protein binding IPI with WITH/FROM = UniProtKB:P21953 (BCKDHB) from
      a study of phosphorylation-based regulation of the human BCKDH complex; the
      recorded interaction is the E1-alpha/E1-beta pairing within E1.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative MF term. The functionally meaningful E1-alpha/E1-beta association
      is captured by the complex membership annotation (GO:0160157) and core_functions.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  qualifier: enables
  review:
    summary: Bare protein binding IPI (BioPlex 2.0 large-scale AP-MS interactome)
      with WITH/FROM = UniProtKB:P21953 (BCKDHB). High-throughput guilt-by-association
      evidence recapitulating the E1-alpha/E1-beta interaction.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative protein binding term derived from a high-throughput screen;
      the E1-alpha/E1-beta relationship is already represented more informatively
      by GO:0160157.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: Bare protein binding IPI (BioPlex 3.0 large-scale AP-MS interactome)
      with WITH/FROM = UniProtKB:P21953 (BCKDHB). High-throughput evidence again capturing
      the E1-alpha/E1-beta interaction.
    action: MARK_AS_OVER_ANNOTATED
    reason: Uninformative MF term from a high-throughput interactome; the E1-alpha/E1-beta
      association is already represented by GO:0160157 and core_functions.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: NAS
  original_reference_id: PMID:3593587
  qualifier: located_in
  review:
    summary: ComplexPortal (CPX-2216) NAS annotation to mitochondrial matrix, consistent
      with the localization of the purified human liver BCKDH complex and with the
      crystallographic/UniProt subcellular location. Correct localization.
    action: ACCEPT
    reason: Mitochondrial matrix localization is well established for the BCKDH complex
      that contains E1-alpha; this NAS is corroborated by IEA (SubCell), ISS, and
      TAS annotations to the same term.
- term:
    id: GO:0009083
    label: branched-chain amino acid catabolic process
  evidence_type: IDA
  original_reference_id: PMID:3593587
  qualifier: involved_in
  review:
    summary: Direct experimental evidence (ComplexPortal, IDA) that the purified human
      liver BCKDH complex oxidizes the three branched-chain 2-oxo acids (KIV, KIC,
      KMV), placing E1-alpha in the BCAA catabolic process. This is the core biological
      process.
    action: ACCEPT
    reason: The purified complex biochemically catabolizes all three branched-chain
      2-oxo acids, directly demonstrating involvement in BCAA catabolism.
    supported_by:
    - reference_id: PMID:3593587
      supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding
        apparent Km values in the range of 14-17 microM for those alpha-keto acids.
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IPI
  original_reference_id: PMID:3593587
  qualifier: part_of
  review:
    summary: ComplexPortal (CPX-2216) evidence that E1-alpha is a subunit of the branched-chain
      alpha-ketoacid dehydrogenase complex, based on purification/characterization
      of the human liver complex showing the constituent subunits. Correct.
    action: ACCEPT
    reason: The purified human liver complex resolves into its component subunits
      (including the ~46-51 kDa E1-alpha/E1-beta bands), establishing E1-alpha as
      part of the BCKDH complex.
    supported_by:
    - reference_id: PMID:3593587
      supporting_text: the purified enzyme complex gave three major bands having molecular
        weights of 51,000, 46,000, and 36,000
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: is_active_in
  review:
    summary: ISS transfer from rat ortholog (UniProtKB:P11178) asserting that E1-alpha
      is active in the mitochondrial matrix. Consistent with all other localization
      evidence; the is_active_in qualifier appropriately reflects where the enzyme
      carries out its function.
    action: ACCEPT
    reason: Mitochondrial matrix is the established site of BCKDH function; the ISS
      is consistent with the direct human localization data.
- term:
    id: GO:0120552
    label: branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
  evidence_type: IMP
  original_reference_id: PMID:10745006
  qualifier: involved_in
  review:
    summary: IMP from the crystal structure/mutational analysis of human E1b, in which
      MSUD-causing E1-alpha variants disrupt cofactor/K+ sites and subunit interfaces
      and abolish function, demonstrating the role of E1-alpha in the branched-chain
      2-oxo acid decarboxylation-to-acyl-CoA process. This BP term precisely captures
      the pathway role of the complex.
    action: ACCEPT
    reason: MSUD mutations in E1-alpha interfere with the cofactor and K+ sites and
      subunit interfaces, impairing the decarboxylation process, providing mutational
      (IMP) evidence for E1-alpha involvement.
    supported_by:
    - reference_id: PMID:10745006
      supporting_text: The known MSUD mutations affect the functioning of E1b by interfering
        with the cofactor and K(+) sites, the packing of hydrophobic cores, and the
        precise arrangement of residues at or near several subunit interfaces.
- term:
    id: GO:0120552
    label: branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
  evidence_type: IDA
  original_reference_id: PMID:3593587
  qualifier: involved_in
  review:
    summary: IDA that the purified human BCKDH complex (containing E1-alpha) carries
      out oxidative decarboxylation of the branched-chain 2-oxo acids to yield NADH
      (and, via the coupled reactions, branched-chain acyl-CoA), placing E1-alpha
      in this pathway.
    action: ACCEPT
    reason: The purified complex oxidizes KIV/KIC/KMV in a CoA- and NAD-dependent
      reaction, the biochemical hallmark of the branched-chain 2-oxo acid decarboxylation-to-acyl-CoA
      pathway.
    supported_by:
    - reference_id: PMID:3593587
      supporting_text: NAD and CoASH were absolutely required for the reaction.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9865121
  qualifier: located_in
  review:
    summary: Reactome TAS localization of the BCKDH reaction to the mitochondrial
      matrix. Correct and consistent with all other localization evidence.
    action: ACCEPT
    reason: Reactome curates the BCKDH-catalyzed reaction as occurring in the mitochondrial
      matrix, consistent with the experimental localization of the complex.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  qualifier: located_in
  review:
    summary: High-throughput (HTP) mitochondrial proteome assignment. Correct but
      less specific than the matrix localization; retained as a broader, consistent
      localization.
    action: ACCEPT
    reason: High-confidence mitochondrial proteome data place E1-alpha in the mitochondrion;
      this is a correct broader parent of the mitochondrial matrix localization.
    supported_by:
    - reference_id: PMID:34800366
      supporting_text: Quantitative high-confidence human mitochondrial proteome and
        its dynamics in cellular context.
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IDA
  original_reference_id: PMID:7883996
  qualifier: part_of
  review:
    summary: IDA from a study of intermediate MSUD in which homozygous E1-alpha missense
      mutations (G245R, F364C) disrupt E1 heterotetrameric (alpha2-beta2) assembly
      and BCKAD complex function, directly demonstrating E1-alpha as a subunit of
      the complex.
    action: ACCEPT
    reason: Mutant E1-alpha subunits fail to assemble the alpha2-beta2 E1 tetramer
      and reconstitute BCKAD activity, establishing E1-alpha membership in the BCKDH
      complex.
    supported_by:
    - reference_id: PMID:7883996
      supporting_text: G245R and F364C mutations in the E1 alpha subunit disrupt both
        the E1 heterotetrameric assembly and function of the BCKAD complex
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IDA
  original_reference_id: PMID:9582350
  qualifier: part_of
  review:
    summary: IDA showing the human E1 decarboxylase comprises two E1-alpha and two
      E1-beta subunits forming an alpha2-beta2 tetramer that is part of the BCKAD
      complex, with type IA MSUD E1-alpha mutations impairing assembly. Directly establishes
      complex membership.
    action: ACCEPT
    reason: Reconstitution/assembly experiments define the alpha2-beta2 E1 component
      containing E1-alpha as part of the branched-chain ketoacid dehydrogenase complex.
    supported_by:
    - reference_id: PMID:9582350
      supporting_text: The E1 decarboxylase component of the human branched-chain
        ketoacid dehydrogenase complex comprises two E1alpha (45.5 kDa) and two E1beta
        (37.5 kDa) subunits forming an alpha2 beta2 tetramer.
- term:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  evidence_type: IDA
  original_reference_id: PMID:10745006
  qualifier: part_of
  review:
    summary: IDA from the crystal structure of the human alpha2-beta2 E1b heterotetramer,
      the E1 component of the BCKDH multienzyme complex, directly demonstrating E1-alpha
      as a structural subunit of the complex.
    action: ACCEPT
    reason: The crystal structure resolves the alpha2-beta2 E1b heterotetramer as
      the E1 component of the branched-chain alpha-ketoacid dehydrogenase complex.
    supported_by:
    - reference_id: PMID:10745006
      supporting_text: the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of
        the branched-chain alpha-ketoacid dehydrogenase multienzyme complex
- term:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:10745006
  qualifier: contributes_to
  review:
    summary: IDA (contributes_to) linking E1-alpha to the branched-chain 2-oxo acid
      dehydrogenase molecular function of the E1 component. The contributes_to qualifier
      is appropriate because the activity is a property of the E1-alpha/E1-beta heterotetramer
      to which E1-alpha contributes catalytic residues (TPP/Mg2+ binding site). This
      is the core molecular function.
    action: ACCEPT
    reason: The crystal structure with TPP, K+ and Mg2+ and characterization of MSUD
      variants (loss of 3-methyl-2-oxobutanoate dehydrogenase activity) establishes
      the contribution of E1-alpha to the branched-chain 2-oxo acid dehydrogenase
      activity.
    supported_by:
    - reference_id: PMID:10745006
      supporting_text: The known MSUD mutations affect the functioning of E1b by interfering
        with the cofactor and K(+) sites
- term:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:9582350
  qualifier: contributes_to
  review:
    summary: IDA (contributes_to) showing that E1-alpha is required for E1 and BCKAD
      catalytic activities; type IA MSUD E1-alpha mutations cause loss of these activities.
      Core molecular function to which E1-alpha contributes within the heterotetramer.
    action: ACCEPT
    reason: In type IA MSUD the affected E1-alpha subunit results in loss of E1 and
      BCKAD catalytic activities, demonstrating the contribution of E1-alpha to the
      branched-chain 2-oxo acid dehydrogenase activity.
    supported_by:
    - reference_id: PMID:9582350
      supporting_text: the E1alpha subunit is affected, resulting in the loss of E1
        and branched-chain ketoacid dehydrogenase catalytic activities
- term:
    id: GO:0009083
    label: branched-chain amino acid catabolic process
  evidence_type: IMP
  original_reference_id: PMID:9582350
  qualifier: involved_in
  review:
    summary: IMP evidence that E1-alpha function is required for branched-chain ketoacid
      dehydrogenase activity, the committed step of BCAA catabolism; type IA MSUD
      E1-alpha mutations abolish this activity. Core biological process.
    action: ACCEPT
    reason: Loss of E1-alpha function in type IA MSUD abolishes BCKAD catalytic activity,
      the committed step of BCAA catabolism, providing mutational evidence for involvement
      in the process.
    supported_by:
    - reference_id: PMID:9582350
      supporting_text: the E1alpha subunit is affected, resulting in the loss of E1
        and branched-chain ketoacid dehydrogenase catalytic activities
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HDA
  original_reference_id: PMID:20833797
  qualifier: located_in
  review:
    summary: High-throughput direct assay (HDA) mitochondrial phosphoproteome localization.
      Correct but broader than the matrix localization; consistent supporting evidence.
    action: ACCEPT
    reason: Phosphoproteomic analysis of functional mitochondria localizes E1-alpha
      to the mitochondrion, a correct broader parent of the mitochondrial matrix localization.
    supported_by:
    - reference_id: PMID:20833797
      supporting_text: Phosphoproteome analysis of functional mitochondria isolated
        from resting human muscle
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5693148
  qualifier: located_in
  review:
    summary: Reactome TAS localization to the mitochondrial matrix. Correct and consistent
      with all other localization evidence.
    action: ACCEPT
    reason: Reactome curates the BCKDH reaction/subunits to the mitochondrial matrix,
      consistent with experimental localization.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5693153
  qualifier: located_in
  review:
    summary: Reactome TAS localization to the mitochondrial matrix. Correct; duplicate
      of the well-supported matrix localization.
    action: ACCEPT
    reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9859148
  qualifier: located_in
  review:
    summary: Reactome TAS localization to the mitochondrial matrix (BCKDHA:BCKDHB
      tetramer decarboxylates KIC, KMVA, KIV reaction). Correct localization of the
      E1-catalyzed step.
    action: ACCEPT
    reason: Reactome localizes the E1 (BCKDHA:BCKDHB) decarboxylation reaction to
      the mitochondrial matrix, consistent with experimental data.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9859163
  qualifier: located_in
  review:
    summary: Reactome TAS localization to the mitochondrial matrix. Correct; consistent
      with all other localization evidence.
    action: ACCEPT
    reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9859172
  qualifier: located_in
  review:
    summary: Reactome TAS localization to the mitochondrial matrix (DLD dimer dehydrogenates
      dihydrolipoyl step of the BCKDH complex). Correct localization; annotated to
      E1-alpha as part of the same complex.
    action: ACCEPT
    reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9865115
  qualifier: located_in
  review:
    summary: Reactome TAS localization to the mitochondrial matrix. Correct; consistent
      duplicate of the matrix localization.
    action: ACCEPT
    reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9907572
  qualifier: located_in
  review:
    summary: Reactome TAS localization to the mitochondrial matrix. Correct; consistent
      duplicate of the matrix localization.
    action: ACCEPT
    reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9912480
  qualifier: located_in
  review:
    summary: Reactome TAS localization to the mitochondrial matrix. Correct; consistent
      duplicate of the matrix localization.
    action: ACCEPT
    reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9912527
  qualifier: located_in
  review:
    summary: Reactome TAS localization to the mitochondrial matrix (H139Hfs13* PPM1K
      does not dephosphorylate BCKDH). Correct localization of the regulated BCKDH
      reaction.
    action: ACCEPT
    reason: Consistent Reactome-curated matrix localization for the BCKDH complex.
- term:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  evidence_type: IDA
  original_reference_id: PMID:7883996
  qualifier: enables
  review:
    summary: IDA (enables) that E1-alpha is required for branched-chain 2-oxo acid
      dehydrogenase activity; intermediate MSUD E1-alpha mutations (G245R, F364C)
      abolish reconstitution of BCKAD activity. This is the core molecular function
      of the gene product.
    action: ACCEPT
    reason: Both intermediate-MSUD E1-alpha mutant subunits fail to reconstitute BCKAD
      activity, demonstrating the requirement of E1-alpha for the branched-chain 2-oxo
      acid dehydrogenase activity.
    supported_by:
    - reference_id: PMID:7883996
      supporting_text: both G245R and F364C mutant E1 alpha subunits were unable to
        significantly reconstitute BCKAD activity
- term:
    id: GO:0009083
    label: branched-chain amino acid catabolic process
  evidence_type: IDA
  original_reference_id: PMID:7883996
  qualifier: involved_in
  review:
    summary: IDA that E1-alpha function is required for BCKAD complex activity, the
      committed step of BCAA catabolism, whose loss (via E1-alpha mutation) causes
      intermediate MSUD. Core biological process.
    action: ACCEPT
    reason: E1-alpha mutations that abolish BCKAD activity cause MSUD (a BCAA catabolic
      defect), demonstrating involvement of E1-alpha in branched-chain amino acid
      catabolism.
    supported_by:
    - reference_id: PMID:7883996
      supporting_text: G245R and F364C mutations in the E1 alpha subunit disrupt both
        the E1 heterotetrameric assembly and function of the BCKAD complex
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: TAS
  original_reference_id: PMID:11839747
  qualifier: located_in
  review:
    summary: TAS (HGNC-UCL) mitochondrial localization derived from a study of the
      human BCKD complex (E2 lipoyl-bearing domain). Correct but broader than the
      matrix localization; the paper concerns the E2/DBT lipoyl domain rather than
      E1-alpha specifically, and is used here as curator-transferred general localization
      for the complex.
    action: ACCEPT
    reason: Mitochondrial localization of the BCKD complex is correct; retained as
      a broader parent of the mitochondrial matrix localization.
    supported_by:
    - reference_id: PMID:11839747
      supporting_text: the human branched-chain alpha-keto acid dehydrogenase complex
- term:
    id: GO:0016831
    label: carboxy-lyase activity
  evidence_type: TAS
  original_reference_id: PMID:11839747
  qualifier: enables
  review:
    summary: TAS (HGNC-UCL) carboxy-lyase activity, a generic parent capturing the
      decarboxylation (CO2-releasing) chemistry of the E1 reaction. The reference
      is actually an NMR study of the E2 lipoyl domain, so this is a curator-assigned
      broad term rather than a direct assay of E1-alpha carboxy-lyase activity. The
      specific molecular function is GO:0003863.
    action: MARK_AS_OVER_ANNOTATED
    reason: Carboxy-lyase activity is a correct but overly general description of
      the E1 decarboxylation step; the precise molecular function branched-chain 2-oxo
      acid dehydrogenase activity (GO:0003863) is already annotated with experimental
      evidence and better represents the role of E1-alpha.
- term:
    id: GO:0030976
    label: thiamine pyrophosphate binding
  evidence_type: IDA
  original_reference_id: PMID:10745006
  qualifier: enables
  review:
    summary: Not present in the seeded GOA but strongly supported. The crystal structure
      of human E1b resolves thiamine diphosphate bound at the E1-alpha/E1-beta interface,
      and UniProt annotates multiple TPP-binding residues on E1-alpha (positions 158,
      159, 207, 239, 240, 265, 336 in mature numbering). Added as a NEW core molecular
      function for the essential cofactor.
    action: NEW
    reason: E1-alpha provides the diphosphate-binding residues of the shared thiamine
      diphosphate cofactor, which is essential for the decarboxylation reaction; this
      MF is documented crystallographically and by UniProt binding features but is
      missing from the current GOA.
    supported_by:
    - reference_id: PMID:10745006
      supporting_text: One of these ions assists a loop that is close to the cofactor
        to adopt the proper conformation.
    - reference_id: file:human/BCKDHA/BCKDHA-deep-research-falcon.md
      supporting_text: The E1 component requires thiamine pyrophosphate (ThDP/TPP)
        as an essential cofactor
- term:
    id: GO:0000287
    label: magnesium ion binding
  evidence_type: IDA
  original_reference_id: PMID:10745006
  qualifier: enables
  review:
    summary: Not present in the seeded GOA but supported by the crystal structure
      and UniProt binding features. Mg2+ is a required cofactor coordinated by E1-alpha
      residues (positions 238, 267, 269 in mature numbering) together with the thiamine
      diphosphate diphosphate moiety. Added as a NEW core molecular function.
    action: NEW
    reason: E1-alpha coordinates the catalytically required Mg2+ that anchors the
      diphosphate of thiamine diphosphate; documented crystallographically and by
      UniProt binding features but missing from the current GOA.
    supported_by:
    - reference_id: file:human/BCKDHA/BCKDHA-uniprot.txt
      supporting_text: Name=Mg(2+)
core_functions:
- description: Thiamine-diphosphate-dependent branched-chain 2-oxo acid dehydrogenase
    (decarboxylase) activity of the E1 component; E1-alpha oxidatively decarboxylates
    the branched-chain 2-oxo acids derived from leucine, isoleucine and valine and
    reductively acylates the lipoyl-lysine of the E2 component (EC 1.2.4.4).
  molecular_function:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  directly_involved_in:
  - id: GO:0120552
    label: branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  in_complex:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  supported_by:
  - reference_id: PMID:10745006
    supporting_text: the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of
      the branched-chain alpha-ketoacid dehydrogenase multienzyme complex
  - reference_id: PMID:9582350
    supporting_text: the E1alpha subunit is affected, resulting in the loss of E1
      and branched-chain ketoacid dehydrogenase catalytic activities
- description: As part of the branched-chain alpha-ketoacid dehydrogenase complex,
    contributes to the committed, rate-limiting step of branched-chain amino acid
    (leucine, isoleucine, valine) catabolism in the mitochondrial matrix.
  molecular_function:
    id: GO:0003863
    label: branched-chain 2-oxo acid dehydrogenase activity
  directly_involved_in:
  - id: GO:0009083
    label: branched-chain amino acid catabolic process
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  in_complex:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  supported_by:
  - reference_id: PMID:3593587
    supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding
      apparent Km values in the range of 14-17 microM for those alpha-keto acids.
- description: Binds the essential cofactor thiamine diphosphate (TPP/ThDP); the diphosphate-binding
    residues and associated divalent metal site reside on the E1-alpha subunit at
    the E1-alpha/E1-beta interface.
  molecular_function:
    id: GO:0030976
    label: thiamine pyrophosphate binding
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  in_complex:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
  supported_by:
  - reference_id: PMID:10745006
    supporting_text: One of these ions assists a loop that is close to the cofactor
      to adopt the proper conformation.
- description: Binds Mg2+, required together with thiamine diphosphate for catalysis;
    the Mg2+-coordinating residues (positions 238, 267, 269 in mature numbering) are
    on the E1-alpha subunit.
  molecular_function:
    id: GO:0000287
    label: magnesium ion binding
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  in_complex:
    id: GO:0160157
    label: branched-chain alpha-ketoacid dehydrogenase complex
proposed_new_terms: []
suggested_questions:
- question: Beyond the canonical alpha2-beta2 E1 heterotetramer, are there physiologically
    distinct assemblies or partners of E1-alpha (e.g. the BCAT2-BCKDH metabolon) that
    alter substrate channeling or flux in specific tissues?
- question: Does phosphorylation of E1-alpha at Ser337 by BCKDK versus dephosphorylation
    by PPM1K act purely as an on/off switch, or does it also modulate substrate specificity
    among the three branched-chain 2-oxo acids?
suggested_experiments:
- description: Cryo-EM of the intact human BCKDH complex (E1/E2/E3 on the DBT core)
    in phosphorylated versus dephosphorylated states to resolve how E1-alpha phosphorylation-loop
    conformation gates the reductive acylation step.
- description: Reconstitution assays comparing kcat/Km of wild-type versus MSUD1A
    E1-alpha variants for KIC, KMV and KIV to test whether specific mutations differentially
    affect the three physiological substrates.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10745006
  title: Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and
    the molecular basis of multienzyme complex deficiency in maple syrup urine disease.
  findings:
  - statement: The 2.7 A crystal structure of the human alpha2-beta2 heterotetrameric
      E1b component reveals the TPP, K+ and Mg2+ sites and explains how MSUD mutations
      disrupt function.
    reference_section_type: ABSTRACT
    supporting_text: the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of
      the branched-chain alpha-ketoacid dehydrogenase multienzyme complex
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: PubMed-verified; structural basis for E1-alpha function, cofactor
      binding, and MSUD variant effects. Cached abstract-only but experimental annotations
      (IDA/IMP) reflect full-text data.
- id: PMID:11839747
  title: Solution structure and dynamics of the lipoic acid-bearing domain of human
    mitochondrial branched-chain alpha-keto acid dehydrogenase complex.
  findings:
  - statement: NMR structure of the E2 (transacylase) lipoyl-bearing domain of the
      human BCKD complex; concerns the E2 lipoyl domain rather than E1-alpha directly.
    reference_section_type: ABSTRACT
    supporting_text: The lipoyl-bearing domain (LBD) of the transacylase (E2) subunit
      of the branched-chain alpha-keto acid dehydrogenase complex plays a central
      role in substrate channeling in this mitochondrial multienzyme complex.
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: Correctly cited but studies the E2/DBT lipoyl domain, not E1-alpha;
      used only as curator-transferred (TAS) broad localization/carboxy-lyase support
      for the complex.
- id: PMID:12902323
  title: 'Roles of His291-alpha and His146-beta'' in the reductive acylation reaction
    catalyzed by human branched-chain alpha-ketoacid dehydrogenase: refined phosphorylation
    loop structure in the active site.'
  findings:
  - statement: Mechanistic study of the human E1b reductive acylation reaction and
      active-site/phosphorylation-loop structure. Source of an E1-alpha/E1-beta protein-binding
      IPI.
    reference_section_type: ABSTRACT
    supporting_text: reductive acylation reaction catalyzed by human branched-chain
      alpha-ketoacid dehydrogenase
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: PubMed-verified; supports the E1-alpha catalytic mechanism. Cited
      in GOA only as a bare protein-binding IPI (WITH/FROM BCKDHB).
- id: PMID:15166214
  title: Cross-talk between thiamin diphosphate binding and phosphorylation loop conformation
    in human branched-chain alpha-keto acid decarboxylase/dehydrogenase.
  findings:
  - statement: Links thiamine diphosphate binding to phosphorylation-loop conformation
      in human E1b. Source of an E1-alpha/E1-beta protein-binding IPI.
    reference_section_type: TITLE
    supporting_text: Cross-talk between thiamin diphosphate binding and phosphorylation
      loop conformation in human branched-chain alpha-keto acid decarboxylase/dehydrogenase.
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: PubMed-verified; supports TPP-binding/regulatory coupling on E1.
      Cited in GOA as bare protein-binding IPI (WITH/FROM BCKDHB).
- id: PMID:15576032
  title: Molecular mechanism for regulation of the human mitochondrial branched-chain
    alpha-ketoacid dehydrogenase complex by phosphorylation.
  findings:
  - statement: Describes phosphorylation-based regulation of the human BCKDH complex.
      Source of an E1-alpha/E1-beta protein-binding IPI.
    reference_section_type: TITLE
    supporting_text: Molecular mechanism for regulation of the human mitochondrial
      branched-chain alpha-ketoacid dehydrogenase complex by phosphorylation.
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: PubMed-verified; supports phospho-regulation of BCKDH. Cited in
      GOA as bare protein-binding IPI (WITH/FROM BCKDHB).
- id: PMID:20833797
  title: Phosphoproteome analysis of functional mitochondria isolated from resting
    human muscle reveals extensive phosphorylation of inner membrane protein complexes
    and enzymes.
  findings:
  - statement: High-throughput direct-assay mitochondrial phosphoproteome placing
      E1-alpha in the mitochondrion.
    reference_section_type: TITLE
    supporting_text: Phosphoproteome analysis of functional mitochondria isolated
      from resting human muscle
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: PubMed-verified; HDA mitochondrial localization support only.
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings:
  - statement: BioPlex 2.0 AP-MS interactome; high-throughput source of the E1-alpha/E1-beta
      protein-binding IPI.
    reference_section_type: TITLE
    supporting_text: Architecture of the human interactome defines protein communities
      and disease networks.
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: PubMed-verified high-throughput screen; only supports a bare protein-binding
      IPI (WITH/FROM BCKDHB).
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings:
  - statement: BioPlex 3.0 AP-MS interactome; high-throughput source of the E1-alpha/E1-beta
      protein-binding IPI.
    reference_section_type: TITLE
    supporting_text: Dual proteome-scale networks reveal cell-specific remodeling
      of the human interactome.
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: PubMed-verified high-throughput screen; only supports a bare protein-binding
      IPI (WITH/FROM BCKDHB).
- id: PMID:34800366
  title: Quantitative high-confidence human mitochondrial proteome and its dynamics
    in cellular context.
  findings:
  - statement: High-throughput high-confidence mitochondrial proteome placing E1-alpha
      in the mitochondrion.
    reference_section_type: TITLE
    supporting_text: Quantitative high-confidence human mitochondrial proteome and
      its dynamics in cellular context.
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: PubMed-verified; HTP mitochondrial localization support only.
- id: PMID:3593587
  title: Purification and characterization of human liver branched-chain alpha-keto
    acid dehydrogenase complex.
  findings:
  - statement: The purified human liver BCKDH complex resolves into E1-alpha/E1-beta/E2
      subunits and oxidizes KIV, KIC and KMV in a NAD- and CoA-dependent reaction.
    reference_section_type: ABSTRACT
    supporting_text: The BCKADH effectively oxidized all of KIV, KIC, and KMV, yielding
      apparent Km values in the range of 14-17 microM for those alpha-keto acids.
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: PubMed-verified; direct biochemical characterization of the human
      complex, substrate specificity, and cofactor requirements.
- id: PMID:7883996
  title: Molecular and biochemical basis of intermediate maple syrup urine disease.
    Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican
    patients.
  findings:
  - statement: Homozygous E1-alpha missense mutations (G245R, F364C) disrupt alpha2-beta2
      E1 assembly and abolish BCKAD activity, causing intermediate MSUD.
    reference_section_type: ABSTRACT
    supporting_text: G245R and F364C mutations in the E1 alpha subunit disrupt both
      the E1 heterotetrameric assembly and function of the BCKAD complex
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: PubMed-verified; mutational evidence for the requirement of E1-alpha
      in complex assembly and catalytic activity.
- id: PMID:9582350
  title: Impaired assembly of E1 decarboxylase of the branched-chain alpha-ketoacid
    dehydrogenase complex in type IA maple syrup urine disease.
  findings:
  - statement: The human E1 decarboxylase is an alpha2-beta2 tetramer of two E1-alpha
      and two E1-beta subunits; type IA MSUD E1-alpha mutations impair assembly and
      abolish E1/BCKAD catalytic activity.
    reference_section_type: ABSTRACT
    supporting_text: The E1 decarboxylase component of the human branched-chain ketoacid
      dehydrogenase complex comprises two E1alpha (45.5 kDa) and two E1beta (37.5
      kDa) subunits forming an alpha2 beta2 tetramer.
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: PubMed-verified; defines the alpha2-beta2 E1 architecture and the
      catalytic consequence of E1-alpha loss in type IA MSUD.
- id: Reactome:R-HSA-5693148
  title: "BCKDK phosphorylates BCKDH"
  findings: []
- id: Reactome:R-HSA-5693153
  title: "PPM1K dephosphorylates p-BCKDH"
  findings: []
- id: Reactome:R-HSA-9859148
  title: "BCKDHA:BCKDHB tetramer decarboxylates KIC, KMVA, KIV"
  findings: []
- id: Reactome:R-HSA-9859163
  title: "DBT transfers BCAA to CoA"
  findings: []
- id: Reactome:R-HSA-9859172
  title: "DLD dimer dehydrogenates dihydrolipoyl"
  findings: []
- id: Reactome:R-HSA-9865115
  title: "DBT loss-of-function mutants don't synthesize BCAA-CoA"
  findings: []
- id: Reactome:R-HSA-9865121
  title: "BCKDHA or BCKDHB loss-of-function mutants don't synthesize BCAA-CoA"
  findings: []
- id: Reactome:R-HSA-9907572
  title: "Loss-of-function DLD mutants don't dehydrogenate dihydrolipoyl DBT"
  findings: []
- id: Reactome:R-HSA-9912480
  title: "BCKDK loss-of-function mutations do not phosphorylate BCKDH"
  findings: []
- id: Reactome:R-HSA-9912527
  title: "H139Hfs13* PPM1K does not dephosphorylate BCKDH"
  findings: []

BCKDHA

Gene Description

Existing Annotations Review

Core Functions

As part of the branched-chain alpha-ketoacid dehydrogenase complex, contributes to the committed, rate-limiting step of branched-chain amino acid (leucine, isoleucine, valine) catabolism in the mitochondrial matrix.

Binds the essential cofactor thiamine diphosphate (TPP/ThDP); the diphosphate-binding residues and associated divalent metal site reside on the E1-alpha subunit at the E1-alpha/E1-beta interface.

Binds Mg2+, required together with thiamine diphosphate for catalysis; the Mg2+-coordinating residues (positions 238, 267, 269 in mature numbering) are on the E1-alpha subunit.

References

Suggested Questions for Experts

Suggested Experiments

Deep Research

Falcon

Comprehensive Research Report: BCKDHA (Branched-Chain Keto Acid Dehydrogenase E1 Subunit Alpha)

Gene and Protein Identity

1. Enzymatic Function and Catalytic Mechanism

1.1 Primary Reaction

1.2 E1 Component and Thiamine Pyrophosphate Dependence

1.3 Substrate Specificity

1.4 Multienzyme Complex Architecture

2. Subcellular Localization

3. Regulatory Mechanisms

3.1 Phosphorylation-Based Regulation

3.2 Tissue-Specific Regulation

3.3 Allosteric Regulation and Metabolon Formation

4. Metabolic Pathway Context

4.1 BCAA Catabolic Pathway

4.2 Integration with Other Metabolic Pathways

5. Disease Associations

5.1 Maple Syrup Urine Disease (MSUD)

5.2 Cardiometabolic Disease

5.3 Cancer

5.4 Diabetes and Metabolic Syndrome

6. Summary

Artifacts

Citations

📚 Additional Documentation

Notes

BCKDHA (P12694) review notes

Summary of verified biology

Key evidence / provenance

Curation decisions (policy-guided)

📄 View Raw YAML